Π£ΠΊΠΎΠ»Ρ‹ Π»Π°Π΅Π½Π½Π΅ΠΊ: Π’Π°Ρˆ Π±Ρ€Π°ΡƒΠ·Π΅Ρ€ устарСл

ΠŸΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ Π›Π°Π΅Π½Π½Π΅ΠΊ: Ρ‡Ρ‚ΠΎ это — состав ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½ΠΎΠ³ΠΎ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Laennec

О ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π΅

Π›Π°Π΅Π½Π½Π΅ΠΊ:

  • ΠžΡ€ΠΈΠ³ΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΉ лСкарствСнный японский ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ Π³Π΅ΠΏΠ°Ρ‚ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΎΡ€ ΠΈ иммунодулятор, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅Ρ‚ΡΡ для лСчСния заболСвания ΠΏΠ΅Ρ‡Π΅Π½ΠΈ ΠΈ укрСплСния ΠΈΠΌΠΌΡƒΠ½ΠΈΡ‚Π΅Ρ‚Π°.
  • Π‘Ρ‹Π» ΠΈΠ·ΠΎΠ±Ρ€Π΅Ρ‚Ρ‘Π½ Π² Π―ΠΏΠΎΠ½ΠΈΠΈ Π² 1956 Π³ΠΎΠ΄Ρƒ ΠΈ Π² настоящСС врСмя ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅Ρ‚ΡΡ Π² 30 странах ΠΌΠΈΡ€Π°

ЀармакотСрапСвтичСская Π³Ρ€ΡƒΠΏΠΏΠ°:
Π˜ΠΌΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰Π΅Π΅ ΠΈ Π³Π΅ΠΏΠ°Ρ‚ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΎΡ€Π½ΠΎΠ΅ срСдство.
ВыпускаСтся Π›Π°Π΅Π½Π½Π΅ΠΊ Π² Π°ΠΌΠΏΡƒΠ»Π°Ρ… ΠΏΠΎ 2 ΠΌΠ».

РСгистрационноС удостовСрСниС лСкарствСнного срСдства β„–013851/01

Π’Ρ…ΠΎΠ΄ΠΈΡ‚ Π² ГосударствСнный рССстр лСкарствСнных срСдств: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=132da942-bff2-4c40-9238-2c6807d0f52f&t=

Π›Π°Π΅Π½Π½Π΅ΠΊ

  • Π‘ΠΎΡ‡Π΅Ρ‚Π°Π½ΠΈΠ΅ Π² Π›Π°Π΅Π½Π½Π΅ΠΊ структурно-пластичСских вСщСств, ΠΎΠ±Π΅ΡΠΏΠ΅Ρ‡ΠΈΠ²Π°ΡŽΡ‰ΠΈΡ… Π½ΠΎΡ€ΠΌΠ°Π»ΡŒΠ½ΡƒΡŽ ΠΆΠΈΠ·Π½Π΅Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ, ΠΈ рСгуляторных ΠΏΠ΅ΠΏΡ‚ΠΈΠ΄ΠΎΠ², ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ Π°ΠΊΡ‚ΠΈΠ²ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‚ Π² ΠΊΠ»Π΅Ρ‚ΠΊΠ°Ρ… процСссы Ρ€Π΅Π³Π΅Π½Π΅Ρ€Π°Ρ†ΠΈΠΈ ΠΈ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ активности, ΠΎΠ±ΡƒΡΠ»Π°Π²Π»ΠΈΠ²Π°ΡŽΡ‚ Π²Ρ‹ΡΠΎΠΊΡƒΡŽ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ΠΈ ΠΏΡ€ΠΈ этом Ρ„ΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°.
  • Π›Π°Π΅Π½Π½Π΅ΠΊ β€” ΠΌΠ½ΠΎΠ³ΠΎΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½Ρ‹ΠΉ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚, состав ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ³ΠΎ Π½Π΅ ограничиваСтся ΠΏΠ΅ΠΏΡ‚ΠΈΠ΄Π°ΠΌΠΈ. Помимо ΠΏΠ΅ΠΏΡ‚ΠΈΠ΄ΠΎΠ², ΠΈΠ½Π³Ρ€Π΅Π΄ΠΈΠ΅Π½Ρ‚Ρ‹ Π›Π°Π΅Π½Π½Π΅ΠΊΠ° прСдставлСны Π³Ρ€ΡƒΠΏΠΏΠ°ΠΌΠΈ вСщСств: аминокислотами, Π²ΠΈΡ‚Π°ΠΌΠΈΠ½Π°ΠΌΠΈ ΠΈ ΠΌΠΈΠΊΡ€ΠΎ- ΠΈ макроэлСмСнтами. ΠŸΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ эффСкты ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° ΠΎΠ±ΡŠΡΡΠ½ΡΡŽΡ‚ΡΡ Π½Π΅ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ синСргичным дСйствиСм ΠΏΠ΅ΠΏΡ‚ΠΈΠ΄ΠΎΠ², Ρ†ΠΈΡ‚ΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ аминокислот, Π½ΠΎ ΠΈ химичСской Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ ΠΌΠ°ΠΊΡ€ΠΎ- ΠΈ микроэлСмСнтов, Π²ΠΈΡ‚Π°ΠΌΠΈΠ½ΠΎΠ².

ΠšΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΠΈΠ΅ эффСкты Π›Π°Π΅Π½Π½Π΅ΠΊ:

  • Π“Π΅ΠΏΠ°Ρ‚ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΎΡ€Π½Ρ‹ΠΉ
  • Π˜ΠΌΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΉ

Π‘Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ

  • Π‘Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ Π›Π°Π΅Π½Π½Π΅ΠΊ Π΄ΠΎΠΊΠ°Π·Π°Π½Π° Π±ΠΎΠ»Π΅Π΅ 60 Π»Π΅Ρ‚Π½ΠΈΠΌ ΠΎΠΏΡ‹Ρ‚ΠΎΠΌ примСнСния Π² Π―ΠΏΠΎΠ½ΠΈΠΈ.
  • ΠšΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΠΈΡ€ΡƒΠ΅Ρ‚ΡΡ Π² Π―ΠΏΠΎΠ½ΠΈΠΈ ГосударствСнной ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΠΎΠΉ ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½ΠΎΠ³ΠΎ оздоровлСния.
  • ΠšΡƒΡ€ΠΈΡ€ΡƒΠ΅Ρ‚ΡΡ ΠΈ дотируСтся мСдицинским Π΄Π΅ΠΏΠ°Ρ€Ρ‚Π°ΠΌΠ΅Π½Ρ‚ΠΎΠΌ ΠΈ являСтся государствСнной страховой ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½ΠΎΠΉ Π―ΠΏΠΎΠ½ΠΈΠΈ.

Π˜Π½ΡΡ‚Ρ€ΡƒΠΊΡ†ΠΈΡ Бостав

японский ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½Ρ‹ΠΉ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚: сСкрСт Π²Π΅Ρ‡Π½ΠΎΠΉ молодости.

Богласно Π΄Ρ€Π΅Π²Π½Π΅ΠΉ Π»Π΅Π³Π΅Π½Π΄Π΅, философский камСнь любоС вСщСство ΠΏΡ€Π΅Π²Ρ€Π°Ρ‰Π°Π΅Ρ‚ Π² Π·ΠΎΠ»ΠΎΡ‚ΠΎ. МногиС ΡƒΡ‡Π΅Π½Ρ‹Π΅ срСдних Π²Π΅ΠΊΠΎΠ² посвятили свои ΠΆΠΈΠ·Π½ΠΈ Π΅Π³ΠΎ Π±Π΅Π·ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎΠΌΡƒ поиску.

Π―ΠΏΠΎΠ½Ρ†Ρ‹ ΠΏΠΎΠ΄Ρ…Π²Π°Ρ‚ΠΈΠ»ΠΈ эстафСту Π°Π»Ρ…ΠΈΠΌΠΈΠΊΠΎΠ². И судя ΠΏΠΎ Π²Ρ‹Π΄Π°ΡŽΡ‰ΠΈΠΌΡΡ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ, ΠΈΠΌ всС-Ρ‚Π°ΠΊΠΈ ΡƒΠ΄Π°Π»ΠΎΡΡŒ ΠΎΡ‚ΠΊΡ€Ρ‹Ρ‚ΡŒ философский камСнь. Π­Ρ‚ΠΎ Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚ ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹ «Π›Π°Π΅Π½Π½Π΅ΠΊ» (Laennec Placenta Extract) – ΠΊΡ€Π°ΠΉΠ½Π΅ эффСктивный стимулятор ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎΠΉ энСргии, созданный Π½Π° основС ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹.Β 

Он бСзопасно ΠΎΠΌΠΎΠ»Π°ΠΆΠΈΠ²Π°Π΅Ρ‚, обновляСт ΠΈ ΠΎΠ·Π΄ΠΎΡ€Π°Π²Π»ΠΈΠ²Π°Π΅Ρ‚ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌ ΠΈΠ·Π½ΡƒΡ‚Ρ€ΠΈ:

    • усиливаСт собствСнный ΠΈΠΌΠΌΡƒΠ½ΠΈΡ‚Π΅Ρ‚,
    • восстанавливаСт ΠΏΠ΅Ρ‡Π΅Π½ΡŒ ΠΈ способствуСт ΠΎΠ±Ρ‰Π΅ΠΉ дСтоксикации ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°,
    • ΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚ ΠΌΠΎΡ‰Π½Ρ‹ΠΉ эффСкт Π»ΠΈΡ„Ρ‚ΠΈΠ½Π³Π°,
    • Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ освСТаСт качСство ΠΊΠΎΠΆΠΈ,
    • систСмно ΡƒΠ»ΡƒΡ‡ΡˆΠ°Π΅Ρ‚ Ρ€Π°Π±ΠΎΡ‚Ρƒ всСх Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½ΠΈΡ… ΠΎΡ€Π³Π°Π½ΠΎΠ²,
    • Π½ΠΎΡ€ΠΌΠ°Π»ΠΈΠ·ΡƒΠ΅Ρ‚ Π²ΡΠ·ΠΊΠΎΡΡ‚ΡŒ ΠΊΡ€ΠΎΠ²ΠΈ ΠΈ слуТит Ρ‚Π΅ΠΌ самым ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΎΠΉ ΠΈΠ½Ρ„Π°Ρ€ΠΊΡ‚ΠΎΠ² ΠΈ ΠΈΠ½ΡΡƒΠ»ΡŒΡ‚ΠΎΠ²,
    • ΡƒΠ»ΡƒΡ‡ΡˆΠ°Π΅Ρ‚ ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠ΅ ΠΊΡ€ΠΎΠ²ΠΎΠΎΠ±Ρ€Π°Ρ‰Π΅Π½ΠΈΠ΅, Π·Ρ€Π΅Π½ΠΈΠ΅, ΠΏΠ°ΠΌΡΡ‚ΡŒ, слух,
    • снимСт стрСсс ΠΈ бСссонницу, ΠΎΠ±Ρ‰Π΅Π΅ напряТСниС;
    • эффСктивно воздСйствуСт Π½Π° ΠΎΡ€Π³Π°Π½Ρ‹ ΠΌΠ°Π»ΠΎΠ³ΠΎ Ρ‚Π°Π·Π° ΠΈ синтСз ΠΏΠΎΠ»ΠΎΠ²Ρ‹Ρ… Π³ΠΎΡ€ΠΌΠΎΠ½ΠΎΠ², устраняСт Ρ„Ρ€ΠΈΠ³ΠΈΠ΄Π½ΠΎΡΡ‚ΡŒ ΠΈ ΠΏΠΎΠ»ΠΎΠ²ΡƒΡŽ ΡΠ»Π°Π±ΠΎΡΡ‚ΡŒ.

Π’Ρ‹ ΡƒΠΆΠ΅ Π·Π½Π°Π΅Ρ‚Π΅, Ρ‡Ρ‚ΠΎ ΡΡ‡Π°ΡΡ‚ΡŒΠ΅ Π½Π΅ опрСдСляСтся дСньгами. Π’Ρ‹ ΡƒΠΆΠ΅ поняли, Ρ‡Ρ‚ΠΎ послС ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ уровня появляСтся страстноС ΠΆΠ΅Π»Π°Π½ΠΈΠ΅ Π±Ρ‹Ρ‚ΡŒ Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹ΠΌ ΠΈ ΠΆΠΈΡ‚ΡŒ Π΄ΠΎΠ»Π³ΠΎ, Ρ‡Ρ‚ΠΎΠ±Ρ‹ Π½Π°ΡΠ»Π°ΠΆΠ΄Π°Ρ‚ΡŒΡΡ достигнутым. ИмСнно эту Π·Π°Π΄Π°Ρ‡Ρƒ ΠΈ Ρ€Π΅ΡˆΠ°Π΅Ρ‚ «Π›Π°Π΅Π½Π½Π΅ΠΊ».

Π’ ΠΊΠ°ΠΊΠΎΠΌ-Ρ‚ΠΎ смыслС, «Π›Π°Π΅Π½Π½Π΅ΠΊ» ΠΌΠΎΠΆΠ½ΠΎ ΡΡ€Π°Π²Π½ΠΈΡ‚ΡŒ с Π²ΠΈΡ‚Π°ΠΌΠΈΠ½Π°ΠΌΠΈ. Π’ΠΏΡ€ΠΎΡ‡Π΅ΠΌ, Π΄Π°ΠΆΠ΅ Π² самыС «ΠΏΡ€ΠΎΠ΄Π²ΠΈΠ½ΡƒΡ‚Ρ‹Π΅» Π²ΠΈΡ‚Π°ΠΌΠΈΠ½Ρ‹ содСрТат Π½Π΅ Π±ΠΎΠ»Π΅Π΅ 30 искусствСнно синтСзированных элСмСнтов, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΡƒΡΠ²Π°ΠΈΠ²Π°ΡŽΡ‚ΡΡ максимум Π½Π° 80%.

Π’Π°ΠΊΠΎΠΉ ΡƒΠ½ΠΈΠΊΠ°Π»ΡŒΠ½Ρ‹ΠΉ состав разностороннС воздСйствуСт Π½Π° Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°.


ΠŸΠ»Π°Ρ†Π΅Π½Ρ‚Π° Π›Π°Π΅Π½Π½Π΅ΠΊ Π²ΠΎ всСм ΠΌΠΈΡ€Π΅ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΡŽΡ‚ΡΡ для лСчСния Π±ΠΎΠ»Π΅Π΅ 80 Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ

    • аллСргия ΠΈ астма,
    • Π°Π΄Π΅Π½ΠΎΠΌΠ° ΠΏΡ€Π΅Π΄ΡΡ‚Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹,
    • Π²Ρ‹ΠΏΠ°Π΄Π΅Π½ΠΈΠ΅ волос,
    • симптомы климакса, особСнно Ρƒ ΠΆΠ΅Π½Ρ‰ΠΈΠ½, ΠΎΡ‚ΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‰ΠΈΡ…ΡΡ ΠΎΡ‚ провСдСния Π—Π“Π’,
    • муТской климакс,
    • Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ ΠΎΠ±ΠΌΠ΅Π½Π° вСщСств, энурСз,
    • ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½Π½ΠΎΠ΅ ΠΈ ΠΏΠΎΠ½ΠΈΠΆΠ΅Π½Π½ΠΎΠ΅ Π΄Π°Π²Π»Π΅Π½ΠΈΠ΅,
    • язва ΠΈ Ρ€Π°ΠΊ ΠΆΠ΅Π»ΡƒΠ΄ΠΊΠ°,
    • эффСктивно заТивляСт Ρ€Π°Π½Ρ‹, борСтся с ΠΊΠ΅Π»ΠΎΠΈΠ΄Π½Ρ‹ΠΌΠΈ Ρ€ΡƒΠ±Ρ†Π°ΠΌΠΈ,
    • хроничСская ΡƒΡΡ‚Π°Π»ΠΎΡΡ‚ΡŒ,
    • Π±ΠΎΠ»Π΅Π·Π½Π΅Π½Π½Ρ‹Π΅ мСнстурации,
    • дисфункция яичников,
    • заболСвания ΠΊΠΎΠΆΠΈ,
    • Π½Π΅Π²Ρ€Π°Π»Π³ΠΈΠΈ, ΠΌΠΈΠ³Ρ€Π΅Π½ΠΈ ΠΈ Π½Π΅Π²Ρ€ΠΎΠ·Ρ‹,
    • остСохондороз ΠΈ Ρ‚.Π΄.

Π’ «ΠŸΠ»Π°Ρ‚ΠΈΠ½Π΅Π½Ρ‚Π°Π»» ΠΌΡ‹ добиваСмся ΠΏΠΎΡ‚Ρ€ΡΡΠ°ΡŽΡ‰ΠΈΡ… эстСтичСских Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ², ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΡ ΠΊΠ°ΠΏΠ΅Π»ΡŒΠ½ΠΈΡ†Ρ‹ с «Π›Π°Π΅Π½Π½Π΅ΠΊ» для ΠΏΡ€Π΅Π΄ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΈ быстрой послСопСрационной Ρ€Π΅Π°Π±ΠΈΠ»ΠΈΡ‚Π°Ρ†ΠΈΠΈ.

ΠŸΠΎΡ‡Π΅ΠΌΡƒ Π² ΠΌΠΈΡ€ΠΎΠ²ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½Π΅ «Π›Π°Π΅Π½Π½Π΅ΠΊ» Π·Π°Π²ΠΎΠ΅Π²Π°Π» Ρ‚Π°ΠΊΠΎΠ΅ ΠΏΡ€ΠΈΠ·Π½Π°Π½ΠΈΠ΅? НС Ρ‚ΠΎΠ»ΡŒΠΊΠΎ Π·Π° свой Π±ΠΎΠ³Π°Ρ‚Ρ‹ΠΉ состав.

ВсС ΠΌΡ‹ Π·Π½Π°Π΅ΠΌ, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈ ΠΏΡ€ΠΈΠ΅ΠΌΠ΅ лСкарствСнных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ² Ρ‚Π°ΠΊ ΠΈΠ»ΠΈ ΠΈΠ½Π°Ρ‡Π΅ ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‚ Π΄Ρ€ΡƒΠ³ΠΈΠ΅ ΠΎΡ€Π³Π°Π½Ρ‹. И ΠΌΡ‹ «ΠΏΠΎ ΡƒΠΌΠΎΠ»Ρ‡Π°Π½ΠΈΡŽ» ΠΏΡ€ΠΈΠ½ΠΈΠΌΠ°Π΅ΠΌ эти ΠΏΡ€Π°Π²ΠΈΠ»Π° ΠΈΠ³Ρ€Ρ‹.

Π‘ΡƒΠ΄ΡƒΡ‡ΠΈ срС

Π² Ρ‡Π΅ΠΌ ΠΏΠΎΠΌΠΎΠ³Π°Π΅Ρ‚ лСкарствСнный ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚?

О японских Β«ΠΊΠ°ΠΏΠ΅Π»ΡŒΠ½ΠΈΡ†Π°Ρ… красоты» Ρƒ нас Π² России ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ Π½Π΅ ΠΌΠ½ΠΎΠ³ΠΎ. И это Π»ΠΈΠ±ΠΎ Ρ€Π΅ΠΊΠ»Π°ΠΌΠ½Ρ‹Π΅ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹, Π»ΠΈΠ±ΠΎ ΡΡ‚Ρ€Π°ΡˆΠ½Ρ‹Π΅ истории с Ρ„ΠΎΡ€ΡƒΠΌΠΎΠ². The Reminder разобрался, Ρ‡Ρ‚ΠΎ это Π·Π° ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚, ΠΊΠΎΠΌΡƒ ΠΎΠ½ ΠΏΠΎΠΌΠΎΠ³Π°Π΅Ρ‚, Π° ΠΊΠΎΠΌΡƒ Π½Π΅ ΠΎΡ‡Π΅Π½ΡŒ.

ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ Π›Π°Π΅Π½Π½Π΅ΠΊ эффСкт

Когда ΠΌΠ½Π΅, ΠΊΠ°ΠΊ Π±ΡŒΡŽΡ‚ΠΈ-Ρ€Π΅Π΄Π°ΠΊΡ‚ΠΎΡ€Ρƒ, ΠΏΡ€Π΅Π΄Π»ΠΎΠΆΠΈΠ»ΠΈ ΠΈΡΠΏΡ‹Ρ‚Π°Ρ‚ΡŒ Π½Π° сСбС дСйствиС Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ» (Laennec), Ρ€Π°Π·Π΄ΡƒΠΌΡ‹Π²Π°Π»Π° я Π΄ΠΎΠ»Π³ΠΎ. Π’ΠΎΡ‚ самый случай, ΠΊΠΎΠ³Π΄Π° Β«ΠΈ хочСтся ΠΈ колСтся».

Π‘ ΠΎΠ΄Π½ΠΎΠΉ стороны, смущало ΡΡ‹Ρ€ΡŒΠ΅, ΠΈΠ· ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ³ΠΎ японцы производят ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚, β€” это чСловСчСская ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°. Π‘ Π΄Ρ€ΡƒΠ³ΠΎΠΉ β€” ΠΊΠ°ΠΊ Ρ€Π°Π· японцы, извСстныС своими Π½Π°ΡƒΡ‡Π½Ρ‹ΠΌΠΈ ΠΏΡ€ΠΎΡ€Ρ‹Π²Π°ΠΌΠΈ ΠΈ инновациями, ΡƒΠΆΠ΅ Π½Π΅ ΠΏΠ΅Ρ€Π²Ρ‹ΠΉ дСсяток Π»Π΅Ρ‚ ΠΈΡΡΠ»Π΅Π΄ΡƒΡŽΡ‚ ΠΈ Π²Π½Π΅Π΄Ρ€ΡΡŽΡ‚ Π² массы ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ. Π Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΡƒ Ρ‚ΠΎΠ³ΠΎ ΠΆΠ΅ Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ» Π½Π°Ρ‡Π°Π» Π΄ΠΎΠΊΡ‚ΠΎΡ€ мСдицинских Π½Π°ΡƒΠΊ Π₯иэда ΠšΡΠ½Ρ‚Π°Ρ€ΠΎ Π² Π΄Π°Π»Π΅ΠΊΠΎΠΌ 1953 Π³ΠΎΠ΄Ρƒ, ΠΊΠΎΠ³Π΄Π° ΠΏΠ΅Ρ€Π΅Π΄ ΡƒΡ‡Π΅Π½Ρ‹ΠΌΠΈ стояла Π·Π°Π΄Π°Ρ‡Π° изобрСсти лСкарство для ΠΏΠΎΠ»Π½ΠΎΠ³ΠΎ восстановлСния ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ° Π² ΠΏΠΎΠΌΠΎΡ‰ΡŒ ΠΏΠΎΡΡ‚Ρ€Π°Π΄Π°Π²ΡˆΠΈΠΌ ТитСлям Π₯иросимы ΠΈ Нагасаки.

Π”ΠΎΠΊΡ‚ΠΎΡ€ ΠšΡΠ½Ρ‚Π°Ρ€ΠΎ, Π²Π΄ΠΎΡ…Π½ΠΎΠ²Π»Π΅Π½Π½Ρ‹ΠΉ Π½Π°ΡƒΡ‡Π½Ρ‹ΠΌΠΈ Ρ‚Ρ€ΡƒΠ΄Π°ΠΌΠΈ совСтского Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΠ° Π’.П. Π€ΠΈΠ»Π°Ρ‚ΠΎΠ²Π° ΠΏΠΎ Ρ‚ΠΊΠ°Π½Π΅Π²ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ, сдСлал ставку Π½Π° ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρƒ ΠΈ Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π» Π½Π° Π΅Π΅ основС ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ для лСчСния ΠΏΠ΅Ρ‡Π΅Π½ΠΈ. Но Π²Ρ‹ΡΡΠ½ΠΈΠ»ΠΎΡΡŒ, Ρ‡Ρ‚ΠΎ Π½ΠΎΠ²ΠΈΠ½ΠΊΠ° ΠΈΠΌΠ΅Π΅Ρ‚ ΠΊΡƒΠ΄Π° Π±ΠΎΠ»Π΅Π΅ ΡˆΠΈΡ€ΠΎΠΊΠΈΠΉ спСктр дСйствия, Ρ‡Π΅ΠΌ просто гСпатопротСкция. А ΠΈΠΌΠ΅Π½Π½ΠΎ β€” иммуномодуляция ΠΈ ΠΎΠΌΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅.

ЭкспСрты Π¦Π΅Π½Ρ‚Ρ€Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ института дСрматокосмСтологии www.cidk.ru:

ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ Π›Π°Π΅Π½Π½Π΅ΠΊ эффСкт

КоТСвникова ΠΠ°Ρ‚Π°Π»ΡŒΡ Π’Π»Π°Π΄ΠΈΠΌΠΈΡ€ΠΎΠ²Π½Π°,

Π²Ρ€Π°Ρ‡-Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΎΠ²Π΅Π½Π΅Ρ€ΠΎΠ»ΠΎΠ³, космСтолог, Ρ‚Ρ€ΠΈΡ…ΠΎΠ»ΠΎΠ³

ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ Π›Π°Π΅Π½Π½Π΅ΠΊ эффСкт

Π―ΠΊΡƒΠ½ΠΈΠ½Π° Π•ΠΊΠ°Ρ‚Π΅Ρ€ΠΈΠ½Π° Π’Π»Π°Π΄ΠΈΠΌΠΈΡ€ΠΎΠ²Π½Π°,

космСтолог-эстСтист

ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ Π›Π°Π΅Π½Π½Π΅ΠΊ эффСкт

Π‘ΠΎΠ±ΠΎΠ»Π΅Π²Π° ЕвгСния АндрССвна,

Π²Ρ€Π°Ρ‡-космСтолог

Β«β€žΠ›Π°Π΅Π½Π½Π΅ΠΊβ€œ относится ΠΊ ΠΊΠ°Ρ‚Π΅Π³ΠΎΡ€ΠΈΠΈ β€žΡƒΠΌΠ½Ρ‹Ρ…β€œ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², β€” Π³ΠΎΠ²ΠΎΡ€ΠΈΡ‚ Π²Ρ€Π°Ρ‡-Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΎΠ²Π΅Π½Π΅Ρ€ΠΎΠ»ΠΎΠ³ ΠΠ°Ρ‚Π°Π»ΡŒΡ КоТСвникова. β€” Π•Π³ΠΎ Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Π΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Ρ‹ Ρ€Π°Π±ΠΎΡ‚Π°ΡŽΡ‚ ΠΈΠΌΠ΅Π½Π½ΠΎ Π½Π° Ρ‚Ρƒ систСму ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°, которая нуТдаСтся Π² Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ. Он сам выявляСт слабыС звСнья ΠΈ приступаСт ΠΊ ΠΈΡ… Π²ΠΎΡΡΡ‚Π°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡŽ Π½Π° ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΌ ΡƒΡ€ΠΎΠ²Π½Π΅Β».

Π§Ρ‚ΠΎ содСрТит Π² сСбС Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ»?

НуклСозиды, Π½ΡƒΠΊΠ»Π΅ΠΎΡ‚ΠΈΠ΄Ρ‹, ΠΏΠ΅ΠΏΡ‚ΠΈΠ΄Ρ‹, Π³Π»ΠΈΠΊΠΎΠ·Π°ΠΌΠΈΠ½ΠΎΠ³Π»ΠΈΠΊΠ°Π½Ρ‹, энзимы, 18 аминокислот, эритропоэтин, ΠΈΠ½Ρ‚Π΅Ρ€Ρ„Π΅Ρ€ΠΎΠ½ Π³Π°ΠΌΠΌΠ°, ΠΈΠ½Ρ‚Π΅Ρ€Π»Π΅ΠΉΠΊΠΈΠ½Ρ‹ 1-6, 8, 10, 12, макроэлСмСнты (N, P, C, S, Na, Mg, Ca, K), микроэлСмСнты (Zn, Br, Si, Fe, Mn, Sc, Se, Cr, V, Cu, Li, B, Co), Π²ΠΈΡ‚Π°ΠΌΠΈΠ½Ρ‹ (Π’1, Π’2, Π’3, Π‘, D, Π Π ) ΠΈ 36 Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² роста, ΡΡ‚ΠΈΠΌΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰ΠΈΡ… ΠΎΠ±Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΊΠ»Π΅Ρ‚ΠΎΠΊ, синтСз ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π° ΠΈ восстановлСниС Π½Π΅Ρ€Π²Π½Ρ‹Ρ… Π²ΠΎΠ»ΠΎΠΊΠΎΠ½.

Β«Π£ΠΌΠ½ΠΎΠ΅Β» лСкарство ΠΈΠ· Π―ΠΏΠΎΠ½ΠΈΠΈ с Π²Π½ΡƒΡˆΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ списком ΠΏΠΎΠ»Π΅Π·Π½Ρ‹Ρ… вСщСств β€” Π·Π²ΡƒΡ‡ΠΈΡ‚ ΠΌΠ½ΠΎΠ³ΠΎΠΎΠ±Π΅Ρ‰Π°ΡŽΡ‰Π΅, ΠΎΠ΄Π½Π°ΠΊΠΎ хочСтся ΡƒΠ·Π½Π°Ρ‚ΡŒ ΠΏΠΎΠ΄Ρ€ΠΎΠ±Π½Π΅Π΅, Ρ‡ΡŒΡ ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π° слуТит ΡΡ‹Ρ€ΡŒΠ΅ΠΌ для ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ?

МСня ΡƒΡΠΏΠΎΠΊΠ°ΠΈΠ²Π°ΡŽΡ‚ Ρ‚Π΅ΠΌ, Ρ‡Ρ‚ΠΎ ΠΎΡ‚Π±ΠΎΡ€ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° Π°Π±ΡΠΎΠ»ΡŽΡ‚Π½ΠΎ Π»Π΅Π³Π°Π»Π΅Π½ ΠΈ этичСн β€” Π½ΠΈ ΠΎΠ΄ΠΈΠ½ ΠΌΠ»Π°Π΄Π΅Π½Π΅Ρ† Π½Π΅ пострадал. Β«Π‘ΠΈΠΎΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹, ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Π΅ для производства β€žΠ›Π°Π΅Π½Π½Π΅ΠΊβ€œ, проходят ΡΡ‚Ρ€ΠΎΠΆΠ°ΠΉΡˆΠΈΠΉ ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ государствСнной ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½ΠΎΠ³ΠΎ оздоровлСния Π―ΠΏΠΎΠ½ΠΈΠΈ, β€” заявляСт Π½Π° своСм сайтС ΠΎΡ„ΠΈΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹ΠΉ ΠΏΡ€Π΅Π΄ΡΡ‚Π°Π²ΠΈΡ‚Π΅Π»ΡŒ Π±Ρ€Π΅Π½Π΄Π° Π² России β€” корпорация Rhana. ΠŸΠ»Π°Ρ†Π΅Π½Ρ‚Π° ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅Ρ‚ΡΡ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ Π² Ρ‚ΠΎΠΌ случаС, Ссли Ρ€ΠΎΠ΄Ρ‹ Π±Ρ‹Π»ΠΈ Π±Π»Π°Π³ΠΎΠΏΠΎΠ»ΡƒΡ‡Π½Ρ‹ΠΌΠΈ, срок бСрСмСнности β€” ΠΏΠΎΠ»Π½Ρ‹ΠΌ, Π° Ρ€ΠΎΠΆΠ΅Π½ΠΈΡ†Π° Π½ΠΈΠΊΠΎΠ³Π΄Π° Π½Π΅ Π²Ρ‹Π΅Π·ΠΆΠ°Π»Π° ΠΈΠ· Π―ΠΏΠΎΠ½ΠΈΠΈ. Π‘ΡƒΠ΄ΡƒΡ‰ΠΈΠ΅ Π΄ΠΎΠ½ΠΎΡ€Ρ‹ Π·Π°Ρ€Π°Π½Π΅Π΅ Π΄Π°ΡŽΡ‚ письмСнноС согласиС Π½Π° использованиС ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹ ΠΈ ΠΏΡ€ΠΎΠ²Π΅Ρ€ΡΡŽΡ‚ΡΡ Π½Π° отсутствиС Π»ΡŽΠ±Ρ‹Ρ… вСнСричСских, ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΎΠ½Π½Ρ‹Ρ… ΠΈ Π΄Ρ€ΡƒΠ³ΠΈΡ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉΒ».

Помимо этичСской стороны вопроса Π²ΠΎΠ»Π½ΡƒΠ΅Ρ‚ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ ΠΏΡ€ΠΈ Π²Π²Π΅Π΄Π΅Π½ΠΈΠΈ Π² ΠΊΡ€ΠΎΠ²ΡŒ Ρ‡ΡƒΠΆΠ΅Ρ€ΠΎΠ΄Π½ΠΎΠ³ΠΎ Π±ΠΈΠΎΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π°.

Β«ΠŸΠ»Π°Ρ†Π΅Π½Ρ‚Π° тСстируСтся нСсколько Ρ€Π°Π·, Π½Π° всСх этапах производства. Π‘ΠΎΠ»Π΅Π΅ Ρ‚ΠΎΠ³ΠΎ, ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½Ρ‹ΠΉ экстракт обСззараТиваСтся Π² ΡΠΏΠ΅Ρ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… условиях, Ρ‡Ρ‚ΠΎΠ±Ρ‹ ΡƒΠ½ΠΈΡ‡Ρ‚ΠΎΠΆΠΈΡ‚ΡŒ ΠΌΠΈΠΊΡ€ΠΎΠ±Ρ‹ ΠΈ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΈ, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΌΠΎΠ³ΡƒΡ‚ Π² Π½Π΅ΠΌ ΠΏΡ€ΠΈΡΡƒΡ‚ΡΡ‚Π²ΠΎΠ²Π°Ρ‚ΡŒ ΠΈ Π½Π΅ ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡ‚ΡŒΡΡ тСстами, β€” увСряСт сайт www.laennec.ru. β€” Π‘Ρ‹Ρ€ΡŒΠ΅ Ρ‚Π°ΠΊΠΆΠ΅ ΠΏΡ€ΠΎΡ…ΠΎΠ΄ΠΈΡ‚ очистку Π½Π° молСкулярном ΡƒΡ€ΠΎΠ²Π½Π΅, для этого ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅Ρ‚ΡΡ тСхнология многоступСнчатого молСкулярного фракционирования. Π’Π°ΠΊ Ρ‡Ρ‚ΠΎ благодаря ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ высокотСхнологичного ΠΌΠ΅Ρ‚ΠΎΠ΄Π° экстракции ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹ ΠΏΡ€ΠΈ ΠΏΠΎΠΌΠΎΡ‰ΠΈ молСкулярной Ρ„ΠΈΠ»ΡŒΡ‚Ρ€Π°Ρ†ΠΈΠΈ Π² ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π΅ ΠΏΠΎΠ»Π½ΠΎΡΡ‚ΡŒΡŽ ΠΎΡ‚ΡΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‚ ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎ опасныС вСщСства».

НаконСц, ΠΌΠ½Π΅ хочСтся Π·Π½Π°Ρ‚ΡŒ, Ρ‡Π΅Π³ΠΎ стоит ΠΎΠΆΠΈΠ΄Π°Ρ‚ΡŒ ΠΎΡ‚ курса ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ» людям со Π·Π΄ΠΎΡ€ΠΎΠ²ΠΎΠΉ ΠΏΠ΅Ρ‡Π΅Π½ΡŒΡŽ?

Β«ΠšΡƒΡ€Ρ ΠΊΠ°ΠΏΠ΅Π»ΡŒΠ½ΠΈΡ† Π΄Π°Π΅Ρ‚ эстСтичСский эффСкт: ΡƒΠ»ΡƒΡ‡ΡˆΠ°Π΅Ρ‚ΡΡ Ρ†Π²Π΅Ρ‚ ΠΈ структура ΠΊΠΎΠΆΠΈ, устраняСтся ΠΎΡ‚Π΅Ρ‡Π½ΠΎΡΡ‚ΡŒ ΠΈ ΠΏΠ°ΡΡ‚ΠΎΠ·Π½ΠΎΡΡ‚ΡŒ, усиливаСтся Ρ‚ΠΎΠΊ Π»ΠΈΠΌΡ„Ρ‹ ΠΈ ΠΊΡ€ΠΎΠ²ΠΈ, Π°ΠΊΡ‚ΠΈΠ²ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‚ΡΡ мСтаболичСскиС процСссы, β€” ΠΎΠ±ΡŠΡΡΠ½ΡΠ΅Ρ‚ ΠΌΠ½Π΅ Π²Ρ€Π°Ρ‡-космСтолог ЕвгСния Π‘ΠΎΠ±ΠΎΠ»Π΅Π²Π°. β€” ΠžΡ‚ Π°ΠΊΠ½Π΅ β€žΠ›Π°Π΅Π½Π½Π΅ΠΊβ€œ Π½Π΅ Π²Ρ‹Π»Π΅Ρ‡ΠΈΡ‚, Π½ΠΎ ΠΎΠ±Ρ‰Π΅Π΅ состояниС ΠΊΠΎΠΆΠΈ ΡƒΠ»ΡƒΡ‡ΡˆΠΈΡ‚Β».

Π’Π°ΠΊΠΆΠ΅ Π½Π΅ лишним Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠΌ ΠΎΡ‚ ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π°Ρ€Π½Ρ‹Ρ… ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ Π±ΡƒΠ΄Π΅Ρ‚:

β€” ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΠ΅ сна;

β€” ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ работоспособности;

β€” сокращСниС частоты обострСний хроничСских Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ;

β€” ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ устойчивости ΠΊ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΎΠ½Π½Ρ‹ΠΌ заболСваниям ΠΈ стрСссовым ситуациям.

Блишком ΠΌΠ½ΠΎΠ³ΠΎ плюсов, Ρ‡Ρ‚ΠΎΠ±Ρ‹ ΡΠΊΠ°Π·Π°Ρ‚ΡŒ Π½Π΅Ρ‚. Π― Π³ΠΎΠ²ΠΎΡ€ΡŽ Π΄Π° ΠΈ Π»ΠΎΠΆΡƒΡΡŒ Π½Π° ΠΊΡƒΡˆΠ΅Ρ‚ΠΊΡƒ. Π”ΠΎΠΊΡ‚ΠΎΡ€ Π‘ΠΎΠ±ΠΎΠ»Π΅Π²Π° прописываСт ΠΌΠ½Π΅ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡŒΠ½ΡƒΡŽ Ρ€Π°Π·ΠΎΠ²ΡƒΡŽ Π΄ΠΎΠ·Ρƒ Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ» (Π΄Π²Π΅ Π°ΠΌΠΏΡƒΠ»Ρ‹ ΠΏΠΎ 2 ΠΌΠ»). ВсСго Ρ‚Ρ€ΠΈ ΠΊΠ°ΠΏΠ΅Π»ΡŒΠ½ΠΈΡ†Ρ‹ β€” для ΠΎΠ·Π½Π°ΠΊΠΎΠΌΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ ΠΈ профилактичСской Ρ†Π΅Π»ΠΈ. ΠŸΠΎΠ»Π½Ρ‹ΠΉ курс Π² эстСтичСских цСлях ΠΏΡ€Π΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅Ρ‚ Π΄Π΅ΡΡΡ‚ΡŒ ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€ с ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒΡŽ Π΄Π²Π°-Ρ‚Ρ€ΠΈ Ρ€Π°Π·Π° Π² нСдСлю, Π²Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½ΠΎ капСльно 4–10 ΠΌΠ» (Π΄Π²Π΅-ΠΏΡΡ‚ΡŒ Π°ΠΌΠΏΡƒΠ») Π½Π° 250 ΠΌΠ» физиологичСского раствора ΠΈΠ»ΠΈ ΠΆΠ΅ Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΡƒΠ½ΠΊΡ‚ΡƒΡ€Π½ΠΎΠ΅ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ β€” 8–12 ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€ с ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒΡŽ ΠΎΠ΄ΠΈΠ½-Π΄Π²Π° Ρ€Π°Π·Π° Π² нСдСлю.

ΠŸΠΎΠ²Ρ‚ΠΎΡ€ΡΡ‚ΡŒ курс Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ»-Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ рСкомСндуСтся ΠΎΠ΄ΠΈΠ½-Π΄Π²Π° Ρ€Π°Π·Π° Π² Π³ΠΎΠ΄. И Π»ΡƒΡ‡ΡˆΠ΅ всСго Π² ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Ρ‹ Π²ΡΠΏΡ‹ΡˆΠ΅ΠΊ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΎΠ½Π½Ρ‹Ρ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, ΠΏΡ€ΠΈ ΠΎΠ±Ρ‰Π΅ΠΌ ослаблСнии ΠΈΠΌΠΌΡƒΠ½Π½ΠΎΠΉ Π·Π°Ρ‰ΠΈΡ‚Ρ‹ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°, Π²ΠΎ врСмя ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… стрСссовых ситуаций, ΠΏΡ€ΠΈ появлСнии синдрома хроничСской усталости, нСдостаткС сна ΠΈ Ρ‚.Π΄.

Β«β€žΠ›Π°Π΅Π½Π½Π΅ΠΊβ€œ ΠΊΠΎΠ»ΡŽΡ‚ ΠΈ Π² Π»ΠΈΡ†ΠΎ, β€” Π³ΠΎΠ²ΠΎΡ€ΠΈΡ‚ Π²Ρ€Π°Ρ‡-космСтолог ЕвгСния Π‘ΠΎΠ±ΠΎΠ»Π΅Π²Π°. β€” Π’Π½ΡƒΡ‚Ρ€ΠΈΠΌΡ‹ΡˆΠ΅Ρ‡Π½ΠΎ ΠΏΠΎ Π»ΠΈΡ„Ρ‚ΠΈΠ½Π³ΠΎΠ²Ρ‹ΠΌ Ρ‚ΠΎΡ‡ΠΊΠ°ΠΌ для ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΡ кровообращСния Π² ΠΌΡ‹ΡˆΡ†Π°Ρ… ΠΈ Π² ΠΏΠΎΠ΄ΠΊΠΎΠΆΠ½ΠΎ-ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ ΠΊΠ»Π΅Ρ‚Ρ‡Π°Ρ‚ΠΊΠ΅. Π—Π° счСт этого ΠΌΡ‹ΡˆΡ†Ρ‹ Π½Π°Ρ‡ΠΈΠ½Π°ΡŽΡ‚ Π»ΡƒΡ‡ΡˆΠ΅ Ρ€Π°Π±ΠΎΡ‚Π°Ρ‚ΡŒ, ΡƒΠ»ΡƒΡ‡ΡˆΠ°Π΅Ρ‚ΡΡ тонус ΠΈ Ρ†Π²Π΅Ρ‚ Π»ΠΈΡ†Π°. Для Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½ΠΎΠ³ΠΎ Π»ΠΈΡ„Ρ‚ΠΈΠ½Π³-эффСкта потрСбуСтся восСмь-Π΄Π΅ΡΡΡ‚ΡŒ ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€ с двумя Π°ΠΌΠΏΡƒΠ»Π°ΠΌΠΈ Π½Π° ΠΊΠ°ΠΆΠ΄ΡƒΡŽ. ΠŸΡ€ΠΈ ΡΠ΅Ρ€ΡŒΠ΅Π·Π½Ρ‹Ρ… ΠΊΠΎΠΆΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ°Ρ… (Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€, атопичСском Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΈΡ‚Π΅ ΠΈ псориазС) потрСбуСтся ΡƒΠΆΠ΅ ΠΏΡΡ‚ΡŒ Π°ΠΌΠΏΡƒΠ» Π½Π° ΠΎΠ΄ΠΈΠ½ сСанс».

ΠšΠ°ΠΏΠ΅Π»ΡŒΠ½ΠΈΡ†Ρƒ ΠΌΠ½Π΅ ставит космСтолог-эстСтист Π¦Π˜Π”Πš Π½Π° Π‘ΠΏΠΈΡ€ΠΈΠ΄ΠΎΠ½ΠΎΠ²ΠΊΠ΅ Π•ΠΊΠ°Ρ‚Π΅Ρ€ΠΈΠ½Π° Π―ΠΊΡƒΠ½ΠΈΠ½Π°. «Никаких ΠΎΠ³Ρ€Π°Π½ΠΈΡ‡Π΅Π½ΠΈΠΉ послС ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€Ρ‹ Π½Π΅Ρ‚, Π½ΠΎ для Π»ΡƒΡ‡ΡˆΠ΅Π³ΠΎ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π° ΠΏΠ΅Ρ‡Π΅Π½ΡŒ Π»ΡƒΡ‡ΡˆΠ΅ Π½Π΅ ΠΏΠ΅Ρ€Π΅Π³Ρ€ΡƒΠΆΠ°Ρ‚ΡŒ тяТСлой ΠΏΠΈΡ‰Π΅ΠΉ ΠΈ Π°Π»ΠΊΠΎΠ³ΠΎΠ»Π΅ΠΌ, β€” совСтуСт ΠΎΠ½Π°. β€” И Ρ‡Ρ‚ΠΎ Π΅Ρ‰Π΅ Ρ…ΠΎΡ€ΠΎΡˆΠΎ, β€žΠ›Π°Π΅Π½Π½Π΅ΠΊβ€œ Π½Π΅ Π΄Π°Π΅Ρ‚ послС ΠΏΠ΅Ρ€Π²Ρ‹Ρ… ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€ обострСний хроничСских болячСк, ΠΊΠ°ΠΊ это Π±Ρ‹Π²Π°Π΅Ρ‚ ΠΏΡ€ΠΈ Π΄Ρ€ΡƒΠ³ΠΈΡ… тСрапиях с Π½Π°ΠΊΠΎΠΏΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ эффСктом. А ΠΏΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ измСнСния β€” Π±ΠΎΠ΄Ρ€ΠΎΡΡ‚ΡŒ, ΡΠ½Π΅Ρ€Π³ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ, ΠΏΡ€ΠΈΠ»ΠΈΠ² сил β€” Π²Ρ‹ Π·Π°ΠΌΠ΅Ρ‚ΠΈΡ‚Π΅ ΠΎΡ‡Π΅Π½ΡŒ скоро».

ПослС ΠΏΠ΅Ρ€Π²ΠΎΠΉ ΠΊΠ°ΠΏΠ΅Π»ΡŒΠ½ΠΈΡ†Ρ‹ я ΠΏΡ€ΠΈΡΠ»ΡƒΡˆΠΈΠ²Π°ΡŽΡΡŒ ΠΊ своим ощущСниям β€” Π²Ρ€ΠΎΠ΄Π΅ всС ΠΊΠ°ΠΊ ΠΎΠ±Ρ‹Ρ‡Π½ΠΎ, Π³ΠΎΠ»ΠΎΠ²Π° Π½Π΅ круТится, Π½Π΅ Ρ‚ΠΎΡˆΠ½ΠΈΡ‚, Π² сон Π½Π΅ ΠΊΠ»ΠΎΠ½ΠΈΡ‚. Но ΠΈ супСрэнСргии Π½Π΅Ρ‚.

Волько Ρ‡Π΅Ρ€Π΅Π· Ρ‚Ρ€ΠΈ ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€Ρ‹, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ Ρ€Π°ΡΡ‚ΡΠ½ΡƒΠ»ΠΈΡΡŒ Π½Π° Ρ‚Ρ€ΠΈ Π½Π΅Π΄Π΅Π»ΠΈ, я Π·Π°ΠΌΠ΅Ρ‡Π°ΡŽ ΠΎΠ±Π΅Ρ‰Π°Π½Π½Ρ‹ΠΉ ΠΏΡ€ΠΈΠ»ΠΈΠ² сил ΠΈ работоспособности. Для сСрСдины Π·ΠΈΠΌΡ‹ ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½Π½ΠΎ Π½Π΅ Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½Ρ‹Π΅.

Π― Ρ‚Π°ΠΊΠΆΠ΅ СдинствСнная ΠΈΠ· всСй Ρ€Π΅Π΄Π°ΠΊΡ†ΠΈΠΈ, ΠΊΡ‚ΠΎ Π½Π΅ свалился с простудой Π² Π½Π°Ρ‡Π°Π»Π΅ фСвраля, хотя Π½ΠΈΠΊΠΎΠ³Π΄Π° Π½Π΅ ΠΌΠΎΠ³Π»Π° ΠΏΠΎΡ…Π²Π°ΡΡ‚Π°Ρ‚ΡŒΡΡ ΠΊΡ€Π΅ΠΏΠΊΠΈΠΌ ΠΈΠΌΠΌΡƒΠ½ΠΈΡ‚Π΅Ρ‚ΠΎΠΌ. Π’ Π·Π΅Ρ€ΠΊΠ°Π»Π΅ особых ΠΏΠ΅Ρ€Π΅ΠΌΠ΅Π½ Π½Π΅ Π²ΠΈΠ΄Π½ΠΎ β€” высыпания Π½Π° ΠΊΠΎΠΆΠ΅ всС Ρ‚Π°ΠΊ ΠΆΠ΅ ΠΏΠΎ Π³Ρ€Π°Ρ„ΠΈΠΊΡƒ (Ρ‚ΠΎ Π΅ΡΡ‚ΡŒ ΠΏΡ€ΠΈ Π°ΠΊΠ½Π΅ Π²Π°ΠΌ Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ» Π²Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½ΠΎ Π΄Π΅ΠΉΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ Π½Π΅ ΠΏΠΎΠΌΠΎΠΆΠ΅Ρ‚), носогубка Π½Π° мСстС, Π»ΠΈΡ„Ρ‚ΠΈΠ½Π³-эффСкт Π½Π΅ Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½. Π—Π°Ρ‚ΠΎ сплю ΠΊΠ°ΠΊ ΠΌΠ»Π°Π΄Π΅Π½Π΅Ρ†, Π±Π»Π°Π³ΠΎΠΏΠΎΠ»ΡƒΡ‡Π½ΠΎ Ρ€ΠΎΠΆΠ΄Π΅Π½Π½Ρ‹ΠΉ Π² срок Π·Π΄ΠΎΡ€ΠΎΠ²ΠΎΠΉ ΠΌΠ°Ρ‚Π΅Ρ€ΡŒΡŽ, Π½ΠΈΠΊΠΎΠ³Π΄Π° Π½Π΅ Π²Ρ‹Π΅Π·ΠΆΠ°Π²ΡˆΠ΅ΠΉ ΠΈΠ· Π―ΠΏΠΎΠ½ΠΈΠΈ.

Π›ΡŽΠ±ΠΎΠΏΡ‹Ρ‚Π½ΠΎ, Ρ‡Ρ‚ΠΎ ΠΆΠ΅ Π±ΡƒΠ΄Π΅Ρ‚, Ссли ΠΏΡ€ΠΎΠΉΡ‚ΠΈ вСсь курс Π΄ΠΎ ΠΊΠΎΠ½Ρ†Π°?

Π§Π΅ΠΌ нас Π»Π΅Ρ‡Π°Ρ‚: Π›Π°Π΅Π½Π½Π΅ΠΊ. ΠŸΠ°Π½Π°Ρ†Π΅Ρ ΠΈΠ»ΠΈ ΠΏΠ»Π°Ρ†Π΅Π±ΠΎ ΠΈΠ· ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹?

КакиС вСщСства содСрТат экстракт чСловСчСской ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹, Ρ‡Ρ‚ΠΎ Π½Π΅ Ρ‚Π°ΠΊ с ΠΏΡ€ΠΈΠ΅ΠΌΠΎΠΌ Π±Π΅Π»ΠΊΠΎΠ²Ρ‹Ρ… лСкарств Π²Π½ΡƒΡ‚Ρ€ΡŒ Π² Π²ΠΈΠ΄Π΅ раствора, Ρ‡Π΅ΠΌ Π›Π°Π΅Π½Π½Π΅ΠΊ Π»ΡƒΡ‡ΡˆΠ΅ Π¦Π΅Ρ€Π΅Π±Ρ€ΠΎΠ»ΠΈΠ·ΠΈΠ½Π° ΠΈ смоТСт Π»ΠΈ ΠΎΠ½ спасти ΠΏΠ΅Ρ‡Π΅Π½ΡŒ, ΠΊΠ°ΠΊ ΠΎΠ±Ρ€Π°Ρ‚ΠΈΡ‚ΡŒ Π²ΡΠΏΡΡ‚ΡŒ ΠΌΠ΅Π½ΠΎΠΏΠ°ΡƒΠ·Ρƒ, Π·Π°Π»Π΅Ρ‡ΠΈΡ‚ΡŒ Ρ€Π°Π½Ρ‹ ΠΈ Π·Π°Π±Ρ‹Ρ‚ΡŒ ΠΎ хроничСской усталости, рассказываСт Indicator.Ru Π² Ρ€ΡƒΠ±Ρ€ΠΈΠΊΠ΅ Β«Π§Π΅ΠΌ нас Π»Π΅Ρ‡Π°Ρ‚Β».

Π›Π°Π΅Π½Π½Π΅ΠΊ β€” Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚ чСловСчСской ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹. Бписок Π΅Π³ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΠΉ ΠΊ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ впСчатляСт:

– Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Π΅ Ρ€Π°Π½Ρ‹ ΠΈ Ρ€ΡƒΠ±Ρ†Ρ‹, Π² Ρ‚ΠΎΠΌ числС ΠΈ слСды послС Π°ΠΊΠ½Π΅;

– хроничСскиС заболСвания ΠΏΠ΅Ρ‡Π΅Π½ΠΈ, ΠΏΠΎΠ²Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΏΠ΅Ρ‡Π΅Π½ΠΈ ΠΈΠ·-Π·Π° алкоголя ΠΈ вирусного Π³Π΅ΠΏΠ°Ρ‚ΠΈΡ‚Π°;

– хроничСская ΡƒΡΡ‚Π°Π»ΠΎΡΡ‚ΡŒ;

– бСсплодиС ΠΈ Π½Π΅ΡƒΠ΄Π°Ρ‡Π½Ρ‹Π΅ ЭКО;

– климакс;

– «сниТСниС ΠΈΠΌΠΌΡƒΠ½ΠΈΡ‚Π΅Ρ‚Π°Β»;

– атопичСский Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΈΡ‚ ΠΈ гСрпСс;

– ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠΈ старСния ΠΈ Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠ³ΠΎ кровообращСния;

Но Ρ‚Π°ΠΊ Π»ΠΈ ΠΎΠΏΡ€Π°Π²Π΄Π°Π½ΠΎ Ρ‚Π°ΠΊΠΎΠ΅ количСство ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΠΉ?

Π’ списках (Π½Π΅) значился

ΠœΡ‹ ΡƒΠΆΠ΅ Π½Π΅ Ρ€Π°Π· ΡΡ‚Π°Π»ΠΊΠΈΠ²Π°Π»ΠΈΡΡŒ с ΠΏΡ€ΠΈΠΌΠ΅Ρ€Π°ΠΌΠΈ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»ΠΈ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… ΠΏΡ€ΠΈ мноТСствС Ρ€Π΅Π³Π°Π»ΠΈΠΉ (Π½Π°Π»ΠΈΡ‡ΠΈΠΈ рСгистрации ΠΈ Π΄Π°ΠΆΠ΅ Π½Π°Π³Ρ€Π°Π΄ Π½Π° Ρ‚Π΅Ρ€Ρ€ΠΈΡ‚ΠΎΡ€ΠΈΠΈ стран БНГ) всС Π΅Ρ‰Π΅ Π½Π΅ ΠΌΠΎΠ³ΡƒΡ‚ Π΄ΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ ΠΈΡ… ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ. Π’ ГосрССстрС лСкарствСнных срСдств упомянуто Ρ‚ΠΎΠ»ΡŒΠΊΠΎ Π΄Π²Π° Π΅Π³ΠΎ клиничСских испытания 2008 Π³ΠΎΠ΄Π°. Они Π΄ΠΎΠ»ΠΆΠ½Ρ‹ Π±Ρ‹Π»ΠΈ ΠΎΠΊΠΎΠ½Ρ‡ΠΈΡ‚ΡŒΡΡ Π² 2009 Π³ΠΎΠ΄Ρƒ (ΠΏΠΎΡ‡Ρ‚ΠΈ Π΄Π΅ΡΡΡ‚ΡŒ Π»Π΅Ρ‚ Π½Π°Π·Π°Π΄), Π½ΠΎ Π΄ΠΎ сих ΠΏΠΎΡ€ Π½Π΅ Π·Π°Π²Π΅Ρ€ΡˆΠ΅Π½Ρ‹. НСсмотря Π½Π° это, Π² 2008 Π³ΠΎΠ΄Ρƒ лСкарство Π±Ρ‹Π»ΠΎ зарСгистрировано ΠΈ ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎ ΠΏΡ€ΠΎΡˆΠ»ΠΎ нСсколько пСрСрСгистраций.

А Π²ΠΎΡ‚ Π½Π° сайтС ЕвропСйского агСнтства ΠΏΠΎ лСкарствСнным срСдствам Π½Π΅Ρ‚ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ ΠΎ ΠΏΠΎΠ΄ΠΎΠ±Π½ΠΎΠΌ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π΅. НСт одобрСния Ρƒ экстракта ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹ ΠΈ ΠΎΡ‚ амСриканского УправлСния ΠΏΠΎ санитарному Π½Π°Π΄Π·ΠΎΡ€Ρƒ Π·Π° качСством ΠΏΠΈΡ‰Π΅Π²Ρ‹Ρ… ΠΏΡ€ΠΎΠ΄ΡƒΠΊΡ‚ΠΎΠ² ΠΈ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½Ρ‚ΠΎΠ² (Food and Drug Administration, FDA).

На Π²ΠΊΠ»Π°Π΄ΠΊΠ΅ «МнСния экспСртов» ΠΎΡ„ΠΈΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ сайта ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° ΠΌΠΎΠΆΠ½ΠΎ Π½Π°ΠΉΡ‚ΠΈ ΠΏΠΎΡ‡Ρ‚ΠΈ Ρ‚Ρ€ΠΈ дСсятка Π²ΠΈΠ΄Π΅ΠΎ β€” ΠΎΡ‚Π·Ρ‹Π²ΠΎΠ² ΠΎΡ‚ Π²Ρ€Π°Ρ‡Π΅ΠΉ, Π² Ρ‚ΠΎΠΌ числС Π΄ΠΎΠΊΡ‚ΠΎΡ€ΠΎΠ² ΠΈ ΠΊΠ°Π½Π΄ΠΈΠ΄Π°Ρ‚ΠΎΠ² Π½Π°ΡƒΠΊ. Π£ Π½Π΅ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… ΠΈΠ· Π½ΠΈΡ… ΠΎΡ‚ΠΊΡ€Ρ‹Ρ‚ΠΎ ΡƒΠΊΠ°Π·Π°Π½Π° аффилиация с ΠΊΠΎΡ€ΠΏΠΎΡ€Π°Ρ†ΠΈΠ΅ΠΉ-ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»Π΅ΠΌ (RHANA). Π’ΠΏΡ€ΠΎΡ‡Π΅ΠΌ, всС Ρ€ΠΎΠ»ΠΈΠΊΠΈ сняты ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠ΅ΠΉ-ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»Π΅ΠΌ, Ρ‚Π°ΠΊ Ρ‡Ρ‚ΠΎ, Π΄Π°ΠΆΠ΅ Ссли Π²Ρ‹ΡΠΊΠ°Π·Π°Π²ΡˆΠΈΠΉΡΡ ΠΊ Π½Π΅ΠΉ ΠΎΡ‚ΠΊΡ€Ρ‹Ρ‚ΠΎ Π½Π΅ относится, ΠΊΠΎΠ½Ρ„Π»ΠΈΠΊΡ‚ интСрСсов Π½Π°Π»ΠΈΡ†ΠΎ. МногиС Ρ€ΠΎΠ»ΠΈΠΊΠΈ ΠΎΡ‚ΠΊΡ€ΠΎΠ²Π΅Π½Π½ΠΎ Ρ€Π΅ΠΊΠ»Π°ΠΌΠ½Ρ‹Π΅: сначала говорится ΠΎ Ρ‚ΠΎΠΌ, ΠΊΠ°ΠΊ Π²Π°ΠΆΠ½ΠΎ ΡΠΎΡ…Ρ€Π°Π½ΡΡ‚ΡŒ Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΠ΅, начиная с роТдСния, рассказываСтся ΠΎΠ± опасностях ΠΆΠΈΠ·Π½ΠΈ Π² стрСссС ΠΈ напряТСнии, ΠΏΠΎΡ‚ΠΎΠΌ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ прСподносится ΠΊΠ°ΠΊ Ρ€Π΅ΡˆΠ΅Π½ΠΈΠ΅.

Π˜Ρ… основной Π°Ρ€Π³ΡƒΠΌΠ΅Π½Ρ‚ полСзности ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π² Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Π° Π΄Π°Π΅Ρ‚ Тизнь Π½ΠΎΠ²ΠΎΠΌΡƒ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΡƒ (Π° Π·Π½Π°Ρ‡ΠΈΡ‚, содСрТит ΠΏΠΎΠ»Π΅Π·Π½Ρ‹Π΅ вСщСства), Ρ‡Ρ‚ΠΎ ΠΎΠ½Π° «самоС сокровСнноС» ΠΈ «самый Π²Π°ΠΆΠ½Ρ‹ΠΉ ΠΎΡ€Π³Π°Π½ Π² Ρ‚Π΅Π»Π΅ Π±Π΅Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΆΠ΅Π½Ρ‰ΠΈΠ½Ρ‹Β». Однако это Π½Π°ΠΏΠΎΠΌΠΈΠ½Π°Π΅Ρ‚ ΡƒΡΡ‚Π°Ρ€Π΅Π²ΡˆΠΈΠ΅ Π²Π΅ΠΊΠ° Π½Π°Π·Π°Π΄ прСдставлСния ΠΎ Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ Π²Π°Π½Π½Π° с ΠΊΡ€ΠΎΠ²ΡŒΡŽ Π½ΠΎΠ²ΠΎΡ€ΠΎΠΆΠ΄Π΅Π½Π½Ρ‹Ρ… ΠΌΠ»Π°Π΄Π΅Π½Ρ†Π΅Π² ΠΎΠΌΠΎΠ»Π°ΠΆΠΈΠ²Π°Π΅Ρ‚ ΠΊΠΎΠΆΡƒ, Π° ΠΏΠ΅Ρ€Π΅Π»ΠΈΠ²Π°Π½ΠΈΠ΅ Β«ΠΌΠΎΠ»ΠΎΠ΄ΠΎΠΉΒ» ΠΊΡ€ΠΎΠ²ΠΈ ΠΏΡ€ΠΎΠ΄Π»Π΅Π²Π°Π΅Ρ‚ Тизнь Ρ€Π΅Ρ†ΠΈΠΏΠΈΠ΅Π½Ρ‚Π°. Π’ ΠΊΡ€ΠΎΠ²ΠΈ Ρ‚ΠΎΠΆΠ΅ содСрТится ΠΎΠ³Ρ€ΠΎΠΌΠ½ΠΎΠ΅ количСство ΠΏΠΎΠ»Π΅Π·Π½Ρ‹Ρ… вСщСств. Но вряд Π»ΠΈ ΠΊΡ‚ΠΎ-Ρ‚ΠΎ станСт ΠΏΡ€ΠΈΡ€Π°Π²Π½ΠΈΠ²Π°Ρ‚ΡŒ ΠΏΠΎ значимости суСвСрия Π² Π΄ΡƒΡ…Π΅ Π•Π»ΠΈΠ·Π°Π²Π΅Ρ‚Ρ‹ Π‘Π°Ρ‚ΠΎΡ€ΠΈ ΠΊ клиничСским испытаниям.

НС Π±ΡƒΠ΄Π΅ΠΌ ΡΠΏΠ΅ΡˆΠΈΡ‚ΡŒ ΠΈ с Π›Π°Π΅Π½Π½Π΅ΠΊΠΎΠΌ: Π΄Π°ΠΆΠ΅ Ссли Π½Π΅ ΠΎΠ±Ρ€Π°Ρ‰Π°Ρ‚ΡŒ внимания Π½Π° явный Ρ€Π΅ΠΊΠ»Π°ΠΌΠ½Ρ‹ΠΉ посыл, Π² Ρ€Π°ΠΌΠΊΠ°Ρ… ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½Ρ‹ ΠΌΠ½Π΅Π½ΠΈΠ΅ экспСртов, основанноС Π½Π° ΠΎΠΏΠΈΡΠ°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… исслСдованиях ΠΈ Π»ΠΈΡ‡Π½ΠΎΠΉ ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅, считаСтся самым Π½ΠΈΠ·ΠΊΠΈΠΌ ΡƒΡ€ΠΎΠ²Π½Π΅ΠΌ Π΄ΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ. Но Ρ€Π΅ΠΊΠ»Π°ΠΌΠ½Ρ‹Π΅ Ρ€ΠΎΠ»ΠΈΠΊΠΈ ΠΌΠΎΠ³ΡƒΡ‚ Π±Ρ‹Ρ‚ΡŒ рассчитаны Π½Π° срСднСстатистичСского покупатСля, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ Π½Π΅ разбираСтся Π² ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½Π΅. А ΠΌΡ‹ Π»ΡƒΡ‡ΡˆΠ΅ рассмотрим, Ρ‡Ρ‚ΠΎ ΠΆΠ΅ Π²Ρ…ΠΎΠ΄ΠΈΡ‚ Π² состав ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°.

Π›Π°Π΅Π½Π½Π΅ΠΊ – инструкция ΠΏΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°, ΠΎΡ‚Π·Ρ‹Π²Ρ‹, Ρ†Π΅Π½Π°, Π°Π½Π°Π»ΠΎΠ³ΠΈ Π—Π½Π°Π΅Ρ‚Π΅ Π»ΠΈ Π²Ρ‹, Ρ‡Ρ‚ΠΎ:

Π‘ΡƒΡ‰Π΅ΡΡ‚Π²ΡƒΡŽΡ‚ ΠΎΡ‡Π΅Π½ΡŒ Π»ΡŽΠ±ΠΎΠΏΡ‹Ρ‚Π½Ρ‹Π΅ мСдицинскиС синдромы, Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€, навязчивоС Π·Π°Π³Π»Π°Ρ‚Ρ‹Π²Π°Π½ΠΈΠ΅ ΠΏΡ€Π΅Π΄ΠΌΠ΅Ρ‚ΠΎΠ². Π’ ΠΆΠ΅Π»ΡƒΠ΄ΠΊΠ΅ ΠΎΠ΄Π½ΠΎΠΉ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠΈ, ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‰Π΅ΠΉ ΠΎΡ‚ этой ΠΌΠ°Π½ΠΈΠΈ, Π±Ρ‹Π»ΠΎ ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½ΠΎ 2500 ΠΈΠ½ΠΎΡ€ΠΎΠ΄Π½Ρ‹Ρ… ΠΏΡ€Π΅Π΄ΠΌΠ΅Ρ‚ΠΎΠ².

74-Π»Π΅Ρ‚Π½ΠΈΠΉ ΠΆΠΈΡ‚Π΅Π»ΡŒ Австралии ДТСймс Π₯аррисон становился Π΄ΠΎΠ½ΠΎΡ€ΠΎΠΌ ΠΊΡ€ΠΎΠ²ΠΈ ΠΎΠΊΠΎΠ»ΠΎ 1000 Ρ€Π°Π·. Π£ Π½Π΅Π³ΠΎ рСдкая Π³Ρ€ΡƒΠΏΠΏΠ° ΠΊΡ€ΠΎΠ²ΠΈ, Π°Π½Ρ‚ΠΈΡ‚Π΅Π»Π° ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠΉ ΠΏΠΎΠΌΠΎΠ³Π°ΡŽΡ‚ Π²Ρ‹ΠΆΠΈΡ‚ΡŒ Π½ΠΎΠ²ΠΎΡ€ΠΎΠΆΠ΄Π΅Π½Π½Ρ‹ΠΌ с тяТСлой Ρ„ΠΎΡ€ΠΌΠΎΠΉ Π°Π½Π΅ΠΌΠΈΠΈ. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, австралиСц спас ΠΎΠΊΠΎΠ»ΠΎ Π΄Π²ΡƒΡ… ΠΌΠΈΠ»Π»ΠΈΠΎΠ½ΠΎΠ² Π΄Π΅Ρ‚Π΅ΠΉ.

ΠšΡ€ΠΎΠΌΠ΅ людСй, ΠΎΡ‚ простатита страдаСт всСго ΠΎΠ΄Π½ΠΎ ΠΆΠΈΠ²ΠΎΠ΅ сущСство Π½Π° ΠΏΠ»Π°Π½Π΅Ρ‚Π΅ ЗСмля – собаки. Π’ΠΎΡ‚ ΡƒΠΆ Π΄Π΅ΠΉΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ наши самыС Π²Π΅Ρ€Π½Ρ‹Π΅ Π΄Ρ€ΡƒΠ·ΡŒΡ.

Когда Π²Π»ΡŽΠ±Π»Π΅Π½Π½Ρ‹Π΅ Ρ†Π΅Π»ΡƒΡŽΡ‚ΡΡ, ΠΊΠ°ΠΆΠ΄Ρ‹ΠΉ ΠΈΠ· Π½ΠΈΡ… тСряСт 6,4 ΠΊΠΊΠ°Π»ΠΎΡ€ΠΈΠΉ Π² ΠΌΠΈΠ½ΡƒΡ‚Ρƒ, Π½ΠΎ ΠΏΡ€ΠΈ этом ΠΎΠ½ΠΈ ΠΎΠ±ΠΌΠ΅Π½ΠΈΠ²Π°ΡŽΡ‚ΡΡ ΠΏΠΎΡ‡Ρ‚ΠΈ 300 Π²ΠΈΠ΄Π°ΠΌΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΉ.

Если Π±Ρ‹ ваша ΠΏΠ΅Ρ‡Π΅Π½ΡŒ пСрСстала Ρ€Π°Π±ΠΎΡ‚Π°Ρ‚ΡŒ, ΡΠΌΠ΅Ρ€Ρ‚ΡŒ наступила Π±Ρ‹ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ суток.

Богласно исслСдованиям, ΠΆΠ΅Π½Ρ‰ΠΈΠ½Ρ‹, Π²Ρ‹ΠΏΠΈΠ²Π°ΡŽΡ‰ΠΈΠ΅ нСсколько стаканов ΠΏΠΈΠ²Π° ΠΈΠ»ΠΈ Π²ΠΈΠ½Π° Π² нСдСлю, ΠΈΠΌΠ΅ΡŽΡ‚ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½Π½Ρ‹ΠΉ риск Π·Π°Π±ΠΎΠ»Π΅Ρ‚ΡŒ Ρ€Π°ΠΊΠΎΠΌ Π³Ρ€ΡƒΠ΄ΠΈ.

ΠŸΠ΅Ρ‡Π΅Π½ΡŒ – это самый тяТСлый ΠΎΡ€Π³Π°Π½ Π² нашСм Ρ‚Π΅Π»Π΅. Π•Π΅ срСдний вСс составляСт 1,5 ΠΊΠ³.

По статистикС, ΠΏΠΎ понСдСльникам риск получСния Ρ‚Ρ€Π°Π²ΠΌ спины увСличиваСтся Π½Π° 25%, Π° риск сСрдСчного приступа – Π½Π° 33%. Π‘ΡƒΠ΄ΡŒΡ‚Π΅ остороТны.

Π›ΡŽΠ΄ΠΈ, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΏΡ€ΠΈΠ²Ρ‹ΠΊΠ»ΠΈ рСгулярно Π·Π°Π²Ρ‚Ρ€Π°ΠΊΠ°Ρ‚ΡŒ, Π³ΠΎΡ€Π°Π·Π΄ΠΎ Ρ€Π΅ΠΆΠ΅ ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‚ ΠΎΠΆΠΈΡ€Π΅Π½ΠΈΠ΅ΠΌ.

Π‘Ρ‚ΠΎΠΌΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈ появились ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ Π½Π΅Π΄Π°Π²Π½ΠΎ. Π•Ρ‰Π΅ Π² 19 Π²Π΅ΠΊΠ΅ Π²Ρ‹Ρ€Ρ‹Π²Π°Ρ‚ΡŒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Π΅ Π·ΡƒΠ±Ρ‹ Π²Ρ…ΠΎΠ΄ΠΈΠ»ΠΎ Π² обязанности ΠΎΠ±Ρ‹Ρ‡Π½ΠΎΠ³ΠΎ ΠΏΠ°Ρ€ΠΈΠΊΠΌΠ°Ρ…Π΅Ρ€Π°.

Для Ρ‚ΠΎΠ³ΠΎ Ρ‡Ρ‚ΠΎΠ±Ρ‹ ΡΠΊΠ°Π·Π°Ρ‚ΡŒ Π΄Π°ΠΆΠ΅ самыС ΠΊΠΎΡ€ΠΎΡ‚ΠΊΠΈΠ΅ ΠΈ простыС слова, ΠΌΡ‹ задСйствуСм 72 ΠΌΡ‹ΡˆΡ†Ρ‹.

ΠšΡ€ΠΎΠ²ΡŒ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ° Β«Π±Π΅Π³Π°Π΅Ρ‚Β» ΠΏΠΎ сосудам ΠΏΠΎΠ΄ ΠΎΠ³Ρ€ΠΎΠΌΠ½Ρ‹ΠΌ Π΄Π°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΈ ΠΏΡ€ΠΈ Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΈ ΠΈΡ… цСлостности способна Π²Ρ‹ΡΡ‚Ρ€Π΅Π»ΠΈΡ‚ΡŒ Π½Π° расстояниС Π΄ΠΎ 10 ΠΌΠ΅Ρ‚Ρ€ΠΎΠ².

Если ΡƒΠ»Ρ‹Π±Π°Ρ‚ΡŒΡΡ всСго Π΄Π²Π° Ρ€Π°Π·Π° Π² дСнь – ΠΌΠΎΠΆΠ½ΠΎ ΠΏΠΎΠ½ΠΈΠ·ΠΈΡ‚ΡŒ кровяноС Π΄Π°Π²Π»Π΅Π½ΠΈΠ΅ ΠΈ ΡΠ½ΠΈΠ·ΠΈΡ‚ΡŒ риск возникновСния ΠΈΠ½Ρ„Π°Ρ€ΠΊΡ‚ΠΎΠ² ΠΈ ΠΈΠ½ΡΡƒΠ»ΡŒΡ‚ΠΎΠ².

Бамая высокая Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€Π° Ρ‚Π΅Π»Π° Π±Ρ‹Π»Π° зафиксирована Ρƒ Π£ΠΈΠ»Π»ΠΈ ДТонса (БША), ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ поступил Π² Π±ΠΎΠ»ΡŒΠ½ΠΈΡ†Ρƒ с Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€ΠΎΠΉ 46,5Β°C.

БрСдняя ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ ΠΆΠΈΠ·Π½ΠΈ лСвшСй мСньшС, Ρ‡Π΅ΠΌ ΠΏΡ€Π°Π²ΡˆΠ΅ΠΉ.

ΠžΡΡ‚Π΅Ρ€Π΅Π³Π°ΠΉΡ‚Π΅ΡΡŒ ΠΏΠΎΠ΄Π΄Π΅Π»ΠΎΠΊ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π›Π°Π΅Π½Π½Π΅ΠΊ

ВсСм заинтСрСсованным Π»ΠΈΡ†Π°ΠΌ

Π£Π²Π°ΠΆΠ°Π΅ΠΌΡ‹Π΅ господа!

ООО ΠœΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΠ°Ρ ΠšΠΎΡ€ΠΏΠΎΡ€Π°Ρ†ΠΈΡ «РАНА» ΠΊΠ°ΠΊ ΡΠΊΡΠΊΠ»ΡŽΠ·ΠΈΠ²Π½Ρ‹ΠΉ дистрибутор лСкарствСнного ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° для мСдицинского примСнСния Β«Π›Π°Π΅Π½Π½Π΅ΠΊΒ» производства ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ Japan Bio Products Co., Ltd.» (JPB Π‘ΠΎ., Ltd.) (Япония) Π² Ρ„ΠΎΡ€ΠΌΠ΅ раствора для ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ (Π² Π°ΠΌΠΏΡƒΠ»Π°Ρ… ΠΏΠΎ 2 ΠΌΠ») ΠΈ Π΄Π΅Ρ€ΠΆΠ°Ρ‚Π΅Π»ΡŒ рСгистрационного удостовСрСния Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°, сообщаСт, Ρ‡Ρ‚ΠΎ с фСвраля 2019 Π³. ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π²Π²ΠΎΠ΄ΠΈΡ‚ Π² ΠΎΠ±Ρ€Π°Ρ‰Π΅Π½ΠΈΠ΅ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ (β„– 10 ΠΈ β„– 50) с Π½ΠΎΠ²Ρ‹ΠΌ ΠΎΡ„ΠΎΡ€ΠΌΠ»Π΅Π½ΠΈΠ΅ΠΌ; ΡΠΎΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠ΅ измСнСния Π² Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Ρ‹, содСрТащиСся Π² рСгистрационном досьС Π½Π° зарСгистрированный лСкарствСнный ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚, согласованы ΠΈ зарСгистрированы ΠœΠΈΠ½ΠΈΡΡ‚Π΅Ρ€ΡΡ‚Π²ΠΎΠΌ ЗдравоохранСния Π Π€ 08.10.2018 Π³.

Π’ соотвСтствии с ΠΏ. 9 ст. 30 Π€Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π·Π°ΠΊΠΎΠ½Π° ΠΎΡ‚ 12 апрСля 2010 Π³. β„– 61-Π€Π— «Об ΠΎΠ±Ρ€Π°Ρ‰Π΅Π½ΠΈΠΈ лСкарствСнных срСдств» ΠΎΠ±Ρ€Π°Ρ‰Π΅Π½ΠΈΠ΅ лСкарствСнного ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° с ΠΏΡ€Π΅Π΄ΡˆΠ΅ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠΌ ΠΎΡ„ΠΎΡ€ΠΌΠ»Π΅Π½ΠΈΠ΅ΠΌ допустимо Π΄ΠΎ истСчСния Π΅Π³ΠΎ срока годности, соотвСтствСнно, Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ ΠΊΠ°ΠΊΠΎΠ³ΠΎ-Ρ‚ΠΎ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ Π½Π° Ρ‚Π΅Ρ€Ρ€ΠΈΡ‚ΠΎΡ€ΠΈΠΈ Π Π€ Π² ΠΎΠ±Ρ€Π°Ρ‰Π΅Π½ΠΈΠΈ Π±ΡƒΠ΄Π΅Ρ‚ лСкарствСнный ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ ΠΊΠ°ΠΊ с Π½ΠΎΠ²Ρ‹ΠΌ ΠΎΡ„ΠΎΡ€ΠΌΠ»Π΅Π½ΠΈΠ΅ΠΌ, Ρ‚Π°ΠΊ ΠΈ с ΠΏΡ€Π΅Π΄ΡˆΠ΅ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠΌ.

Гарантиями качСства ΠΈ бСзопасности ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° являСтся ΠΏΡ€ΠΈΠΎΠ±Ρ€Π΅Ρ‚Π΅Π½ΠΈΠ΅ Π΅Π³ΠΎ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ Ρƒ ООО ΠœΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΠ°Ρ ΠšΠΎΡ€ΠΏΠΎΡ€Π°Ρ†ΠΈΡ «РАНА» ΠΈ Π΅Π³ΠΎ ΠΎΡ„ΠΈΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… прСдставитСлСй, информация ΠΎ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… прСдставлСна Π½Π° сайтах ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ β€” http://laennec.ru, Π° Ρ‚Π°ΠΊΠΆΠ΅ Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ Ρ„ΠΈΡ€ΠΌΠ΅Π½Π½ΠΎΠΉ русифицированной ΡƒΠΏΠ°ΠΊΠΎΠ²ΠΊΠΈ, ΡΠΏΠ΅Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎ Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π½ΠΎΠΉ для поставок ΠΈ ΠΏΡ€ΠΎΠ΄Π°ΠΆ Π½Π° Ρ‚Π΅Ρ€Ρ€ΠΈΡ‚ΠΎΡ€ΠΈΠΈ Π Π€ ΠΈ ΡƒΡ‚Π²Π΅Ρ€ΠΆΠ΄Π΅Π½Π½ΠΎΠΉ ΠœΠ˜ΠΠ—Π”Π ΠΠ’ΠžΠœ Π ΠžΠ‘Π‘Π˜Π™Π‘ΠšΠžΠ™ Π€Π•Π”Π•Π ΠΠ¦Π˜Π˜, Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ Π·Π°Ρ‰ΠΈΡ‚Π½ΠΎΠΉ Π³ΠΎΠ»ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ ΠΈ контроля вскрытия, ΠΈΠ΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π½ΠΎΠΌΠ΅Ρ€Π° ΠΏΡ€ΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½Π½ΠΎΠΉ сСрии ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° (ΡƒΠΊΠ°Π·Π°Π½ Π½Π° ΠΎΠ±Ρ€Π°Ρ‚Π½ΠΎΠΉ сторонС ΡƒΠΏΠ°ΠΊΠΎΠ²ΠΊΠΈ, Ρ‚ΠΎΡ‚ ΠΆΠ΅ Π½ΠΎΠΌΠ΅Ρ€ ΠΎΠ±ΠΎΠ·Π½Π°Ρ‡Π΅Π½ Π½Π° ΠΊΠ°ΠΆΠ΄ΠΎΠΉ Π°ΠΌΠΏΡƒΠ»Π΅) ΠΈ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ ΠΎ дистрибуторС (ΠΎΠ±ΡΠ·Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ присутствиС Π»ΠΎΠ³ΠΎΡ‚ΠΈΠΏΠ° RHANA). Π˜Π·ΠΎΠ±Ρ€Π°ΠΆΠ΅Π½ΠΈΡ ΠΎΡ€ΠΈΠ³ΠΈΠ½Π°Π»ΡŒΠ½ΠΎΠΉ ΠΏΡ€ΠΎΠ΄ΡƒΠΊΡ†ΠΈΠΈ ΠΈ срСдств Π΅Π΅ ΠΈΠ΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ ΠΈ Π·Π°Ρ‰ΠΈΡ‚Ρ‹ (ΠΊΠ°ΠΊ с Π½ΠΎΠ²Ρ‹ΠΌ ΠΎΡ„ΠΎΡ€ΠΌΠ»Π΅Π½ΠΈΠ΅ΠΌ, Ρ‚Π°ΠΊ ΠΈ с ΠΏΡ€Π΅Π΄ΡˆΠ΅ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠΌ) ΠΌΠΎΠΆΠ½ΠΎ ΠΏΡ€ΠΎΠ²Π΅Ρ€ΠΈΡ‚ΡŒ Π½Π° сайтС ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ β€” http://laennec.ru, ΡƒΠΊΠ°Π·Π°Π² Π½ΠΎΠΌΠ΅Ρ€ сСрии ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°.

ΠŸΡ€Π΅Π΄Π»Π°Π³Π°Π΅ΠΌΡ‹Π΅ ΠΊ ΠΏΡ€ΠΎΠ΄Π°ΠΆΠ΅ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Ρ‹ Π² нСрусифицированных ΡƒΠΏΠ°ΠΊΠΎΠ²ΠΊΠ°Ρ…, ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Ρ‹ производства Π½Π΅ Π·Π°Π²ΠΎΠ΄Π° «Japan Bio Products Co., Ltd.» (JPB Π‘ΠΎ., Ltd.) (Япония) ΡΠ²Π»ΡΡŽΡ‚ΡΡ, ΠΊΠ°ΠΊ ΠΌΠΈΠ½ΠΈΠΌΡƒΠΌ, Π½Π΅Π»Π΅Π³Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ ΠΈ ΠΊΠΎΠ½Ρ‚Ρ€Π°Ρ„Π°ΠΊΡ‚Π½Ρ‹ΠΌΠΈ. Ни компания ΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»ΡŒ, Π½ΠΈ Π΅Ρ‘ ΡΠΊΡΠΊΠ»ΡŽΠ·ΠΈΠ²Π½Ρ‹ΠΉ дистрибутор Π½Π΅ нСсут отвСтствСнности Π·Π° качСство ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ Π΄Π°Π½Π½Ρ‹Ρ… ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ².

Π‘ΡƒΠ΄ΡŒΡ‚Π΅ остороТны ΠΏΡ€ΠΈ ΠΏΡ€ΠΈΠΎΠ±Ρ€Π΅Ρ‚Π΅Π½ΠΈΠΈ лСкарствСнных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ².

ΠšΡ€ΠΎΠΌΠ΅ Ρ‚ΠΎΠ³ΠΎ, ΠΏΠΎΡΠΊΠΎΠ»ΡŒΠΊΡƒ ΠΈΡΠΊΠ»ΡŽΡ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ ΠΏΡ€Π°Π²ΠΎ Π½Π° использованиС Ρ‚ΠΎΠ²Π°Ρ€Π½ΠΎΠ³ΠΎ Π·Π½Π°ΠΊΠ° Π›ΠΠ•ΠΠΠ•Πš Π½Π° Ρ‚Π΅Ρ€Ρ€ΠΈΡ‚ΠΎΡ€ΠΈΠΈ Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ Π² ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠΈ, Π² Ρ‚ΠΎΠΌ числС, ΡΠΎΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… лСкарствСнных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ² ΠΈ мСдицинских услуг, ΠΏΡ€ΠΈΠ½Π°Π΄Π»Π΅ΠΆΠΈΡ‚ ООО ΠœΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΠ°Ρ ΠšΠΎΡ€ΠΏΠΎΡ€Π°Ρ†ΠΈΡ «РАНА» (ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎ Π½Π° Ρ‚ΠΎΠ²Π°Ρ€Π½Ρ‹ΠΉ Π·Π½Π°ΠΊ β„– 552870), ΠΏΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½ΠΈΠ΅ ΠΊ ΠΏΡ€ΠΎΠ΄Π°ΠΆΠ΅, ΠΏΡ€ΠΎΠ΄Π°ΠΆΠ° ΠΈ использованиС для оказания услуг Ρ‚Ρ€Π΅Ρ‚ΡŒΠΈΠΌΠΈ Π»ΠΈΡ†Π°ΠΌΠΈ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ² с использованиСм обозначСния Π›ΠΠ•ΠΠΠ•Πš ΠΈΠ»ΠΈ сходных с Π½ΠΈΠΌ ΠΎΠ±ΠΎΠ·Π½Π°Ρ‡Π΅Π½ΠΈΠΉ (LAENNEC, LAENEC, LAENNEK, Π›ΠΠ•ΠΠ•Πš ΠΈ Ρ‚.Π΄.) Π±Π΅Π· ΡΠΎΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²ΡƒΡŽΡ‰Π΅Π³ΠΎ Ρ€Π°Π·Ρ€Π΅ΡˆΠ΅Π½ΠΈΡ являСтся Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠ΅ΠΌ ΠΈΡΠΊΠ»ΡŽΡ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€Π°Π² Π½Π° Ρ‚ΠΎΠ²Π°Ρ€Π½Ρ‹ΠΉ Π·Π½Π°ΠΊ, Π·Π° ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ΅ Π·Π°ΠΊΠΎΠ½ΠΎΠ΄Π°Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎΠΌ прСдусмотрСна ΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²Π΅Π½Π½ΠΎΡΡ‚ΡŒ, Π² Ρ‚ΠΎΠΌ числС уголовная. Π’ΠΎ ΠΈΠ·Π±Π΅ΠΆΠ°Π½ΠΈΠ΅ ΠΏΡ€Π΅Ρ‚Π΅Π½Π·ΠΈΠΉ ΠΎ Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΈ ΠΏΡ€Π°Π² Π½Π° Ρ‚ΠΎΠ²Π°Ρ€Π½Ρ‹ΠΉ Π·Π½Π°ΠΊ ΠΈΠ·Π±Π΅Π³Π°ΠΉΡ‚Π΅ приобрСтСния ΠΈ использования ΠΊΠΎΠ½Ρ‚Ρ€Π°Ρ„Π°ΠΊΡ‚Π½Ρ‹Ρ… ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ².

О нас Π΄Π΅Ρ‚Π°Π»ΡŒΠ½Π°Ρ

ИНБВРУКЦИЯ
ΠΏΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ лСкарствСнного ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° для
мСдицинского примСнСния
Π›ΠΠ•ΠΠΠ•Πš

РСгистрационный Π½ΠΎΠΌΠ΅Ρ€: П β„–013851/01

Π’ΠΎΡ€Π³ΠΎΠ²ΠΎΠ΅ Π½Π°Π·Π²Π°Π½ΠΈΠ΅: Π›Π°Π΅Π½Π½Π΅ΠΊ

ЛСкарствСнная Ρ„ΠΎΡ€ΠΌΠ°: раствор для ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ

Бостав Π’ 2 ΠΌΠ» ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° содСрТится Β­112 ΠΌΠ³ Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚Π° ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°, Π²ΠΎΠ΄Π° для ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ, ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ‚ΠΎΡ€ рН (натрия гидроксид ΠΈΠ»ΠΈ кислота хлористоводородная).

ОписаниС ΠŸΡ€ΠΎΠ·Ρ€Π°Ρ‡Π½Π°Ρ ΠΆΠΈΠ΄ΠΊΠΎΡΡ‚ΡŒ ΠΎΡ‚ свСтло-ΠΆΠ΅Π»Ρ‚ΠΎΠ³ΠΎ Π΄ΠΎ ΠΊΠΎΡ€ΠΈΡ‡Π½Π΅Π²ΠΎΠ³ΠΎ Ρ†Π²Π΅Ρ‚Π° с Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€Π½Ρ‹ΠΌ Π·Π°ΠΏΠ°Ρ…ΠΎΠΌ.

ЀармакотСрапСвтичСская Π³Ρ€ΡƒΠΏΠΏΠ° Π˜ΠΌΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰Π΅Π΅ ΠΈ Π³Π΅ΠΏΠ°Ρ‚ΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΊΡ‚ΠΎΡ€Π½ΠΎΠ΅ срСдство.

Код АВΠ₯: L03, А05ВА

ЀармакологичСскиС свойства Π›Π°Π΅Π½Π½Π΅ΠΊ проявляСт ΠΈΠΌΠΌΡƒΠ½ΠΎΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠ΅ свойства Π·Π° счСт способности ΡΡ‚ΠΈΠΌΡƒΠ»ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ Π³ΡƒΠΌΠΎΡ€Π°Π»ΡŒΠ½Ρ‹ΠΉ ΠΈΠΌΠΌΡƒΠ½ΠΈΡ‚Π΅Ρ‚ ΠΈ ΠΏΠΎΠ²Ρ‹ΡˆΠ°Ρ‚ΡŒ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Ρ„Π°Π³ΠΎΡ†ΠΈΡ‚ΠΎΠ² ΠΈ СстСствСнных ΠΊΠΈΠ»Π»Π΅Ρ€ΠΎΠ²; ΡƒΠ²Π΅Π»ΠΈΡ‡ΠΈΠ²Π°Π΅Ρ‚ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΡ†ΠΈΠ΄Π½ΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Π»Π΅ΠΉΠΊΠΎΡ†ΠΈΡ‚ΠΎΠ² пСрифСричСской ΠΊΡ€ΠΎΠ²ΠΈ, ΠΏΡ€ΠΎΡΠ²Π»ΡΡŽΡ‰ΡƒΡŽΡΡ Π² ΠΈΡ… способности ΡƒΠ½ΠΈΡ‡Ρ‚ΠΎΠΆΠ°Ρ‚ΡŒ Π·Π°Ρ…Π²Π°Ρ‡Π΅Π½Π½Ρ‹ΠΉ Π²ΠΎΠ·Π±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒ. Π¦ΠΈΡ‚ΠΎΠΊΠΈΠ½Ρ‹, входящиС Π² состав ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°, Π°ΠΊΡ‚ΠΈΠ²ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‚ ΠΌΠ΅Ρ‚Π°Π±ΠΎΠ»ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΠΈ Π½Π°Π΄Π·ΠΎΡ€Π½ΡƒΡŽ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΠΊΠ»Π΅Ρ‚ΠΎΠΊ ΠΊΠΎΠΆΠΈ.

БиологичСски Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Π΅ вСщСства, находящиСся Π² Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚Π΅, ΡΡ‚ΠΈΠΌΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‚ Ρ€Π΅Π³Π΅Π½Π΅Ρ€Π°Ρ†ΠΈΡŽ (ΠΏΡ€ΠΎΠ»ΠΈΡ„Π΅Ρ€Π°Ρ†ΠΈΡŽ) Π³Π΅ΠΏΠ°Ρ‚ΠΎΡ†ΠΈΡ‚ΠΎΠ², ΠΏΡ€ΠΎΡΠ²Π»ΡΡŽΡ‚ дСзинтоксикационныС свойства, ΡΠ½ΠΈΠΆΠ°ΡŽΡ‚ ΠΎΡ‚Π»ΠΎΠΆΠ΅Π½ΠΈΠ΅ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ² ΠΈ холСстСрина Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΎΡ‡Π½Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΊΠ°Ρ…, ΠΏΠΎΠ²Ρ‹ΡˆΠ°ΡŽΡ‚ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Ρ‚ΠΊΠ°Π½Π΅Π²ΠΎΠ³ΠΎ дыхания, Π°ΠΊΡ‚ΠΈΠ²ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‚ ΠΎΠ±ΠΌΠ΅Π½ вСщСств Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΈ, ΡΠ½ΠΈΠΆΠ°ΡŽΡ‚ ΠΈΠ½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΠΎΡΡ‚ΡŒ развития ΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ Ρ‚ΠΊΠ°Π½ΠΈ Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΈ.

Показания ΠΊ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ ΠŸΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ примСняСтся Π² комплСксной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΡΠ»Π΅Π΄ΡƒΡŽΡ‰ΠΈΡ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ: хроничСский Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΉ гСрпСс, атопичСский Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΈΡ‚ срСднСтяТСлого ΠΈ тяТСлого тСчСния (Π² Ρ‚ΠΎΠΌ числС, ослоТнСнный). Π’ Π²ΠΈΠ΄Π΅ ΠΌΠΎΠ½ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΏΡ€ΠΈ хроничСских заболСваниях ΠΏΠ΅Ρ‡Π΅Π½ΠΈ: стСатогСпатитах (алкогольной, мСтаболичСской ΠΈ смСшанной этиологии).

ΠŸΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΡ Π“ΠΈΠΏΠ΅Ρ€Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ, дСтский возраст, Π±Π΅Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΡΡ‚ΡŒ, ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ Π»Π°ΠΊΡ‚Π°Ρ†ΠΈΠΈ.

Π‘ ΠΎΡΡ‚ΠΎΡ€ΠΎΠΆΠ½ΠΎΡΡ‚ΡŒΡŽ Π‘ ΠΎΡΡ‚ΠΎΡ€ΠΎΠΆΠ½ΠΎΡΡ‚ΡŒΡŽ слСдуСт ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡ‚ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‰ΠΈΡ… ΠΏΠΎΠ»ΠΈΠ²Π°Π»Π΅Π½Ρ‚Π½ΠΎΠΉ Π°Π»Π»Π΅Ρ€Π³ΠΈΠ΅ΠΉ Π½Π° лСкарствСнныС ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Ρ‹, Π° Ρ‚Π°ΠΊΠΆΠ΅ Ρƒ Π»ΠΈΡ† ΠΏΠΎΠΆΠΈΠ»ΠΎΠ³ΠΎ возраста.

Бпособ примСнСния ΠΈ Π΄ΠΎΠ·Ρ‹

  • ΠŸΡ€ΠΈ хроничСском Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²ΠΈΡ€ΡƒΡŽΡ‰Π΅ΠΌ гСрпСсС ΠΈ атопичСском Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΈΡ‚Π΅: Π²Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½ΠΎΠ΅ капСльноС Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅: 10 ΠΌΠ» (560 ΠΌΠ³ Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚Π° ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹) ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° (5 Π°ΠΌΠΏΡƒΠ») Ρ€Π°ΡΡ‚Π²ΠΎΡ€ΡΡŽΡ‚ Π² 250 -500 ΠΌΠ» 5% раствора дСкстрозы ΠΈΠ»ΠΈ физиологичСского раствора ΠΈ вводят Ρ‡Π΅Ρ€Π΅Π· Π»ΠΎΠΊΡ‚Π΅Π²ΡƒΡŽ Π²Π΅Π½Ρƒ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 1,5 — 2 часов. Π˜Π½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ проводят 3 Ρ€Π°Π·Π° Π² нСдСлю с ΠΈΠ½Ρ‚Π΅Ρ€Π²Π°Π»ΠΎΠΌ Π² 2 дня. ΠšΡƒΡ€Ρ лСчСния 10 ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ.
  • ΠŸΡ€ΠΈ хроничСских заболСваниях ΠΏΠ΅Ρ‡Π΅Π½ΠΈ: стСатогСпатитах (алкогольной, мСтаболичСской ΠΈ смСшанной этиологии): Π²Π½ΡƒΡ‚Ρ€ΠΈΠΌΡ‹ΡˆΠ΅Ρ‡Π½ΠΎ: ΠΏΠΎ 2 ΠΌΠ» Π² сутки (112 ΠΌΠ³ Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚Π° ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹). Π’ зависимости ΠΎΡ‚ тяТСсти заболСвания частота ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ ΠΌΠΎΠΆΠ΅Ρ‚ Π±Ρ‹Ρ‚ΡŒ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½Π° Π΄ΠΎ 2 -3 Ρ€Π°Π· (Π΄ΠΎ 6 ΠΌΠ») Π² сутки; Π²Π½ΡƒΡ‚Ρ€ΠΈΠ²Π΅Π½Π½ΠΎΠ΅ капСльноС Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅: 10 ΠΌΠ» (560 ΠΌΠ³ Π³ΠΈΠ΄Ρ€ΠΎΠ»ΠΈΠ·Π°Ρ‚Π° ΠΏΠ»Π°Ρ†Π΅Π½Ρ‚Ρ‹) ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° (5 Π°ΠΌΠΏΡƒΠ») Ρ€Π°ΡΡ‚Π²ΠΎΡ€ΡΡŽΡ‚ Π² 250 -500 ΠΌΠ» 5% раствора дСкстрозы ΠΈΠ»ΠΈ физиологичСского раствора ΠΈ вводят Ρ‡Π΅Ρ€Π΅Π· Π»ΠΎΠΊΡ‚Π΅Π²ΡƒΡŽ Π²Π΅Π½Ρƒ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 1,5 — 2 часов. Π˜Π½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ проводят Π΅ΠΆΠ΅Π΄Π½Π΅Π²Π½ΠΎ. ΠšΡƒΡ€Ρ лСчСния 2- 3 Π½Π΅Π΄Π΅Π»ΠΈ.

ΠŸΠΎΠ±ΠΎΡ‡Π½ΠΎΠ΅ дСйствиС ΠžΡ‚ΠΌΠ΅Ρ‡Π°Π΅Ρ‚ΡΡ Ρƒ 3,7% Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ….

ΠšΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΠΈ Π·Π½Π°Ρ‡ΠΈΠΌΡ‹Π΅ Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Ρ€Π΅Π°ΠΊΡ†ΠΈΠΈ.

Π’ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹ аллСргичСскиС Ρ€Π΅Π°ΠΊΡ†ΠΈΠΈ, Π² Ρ‚ΠΎΠΌ числС анафилактичСский шок.

Π”Ρ€ΡƒΠ³ΠΈΠ΅ Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ явлСния

Π‘ΠΎΠ»Π΅Π·Π½Π΅Π½Π½ΠΎΡΡ‚ΡŒ Π² мСстС ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ 2.56%
АллСргичСскиС Ρ€Π΅Π°ΠΊΡ†ΠΈΠΈ (покраснСниС, Π·ΡƒΠ΄ ΠΊΠΎΠΆΠΈ) 0.37%
ОнСмСнСниС Π² мСстС ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΈ 0.37%
ГинСкомастия (ΠΏΡ€ΠΈΡ‡ΠΈΠ½Π½ΠΎ-слСдствСнная связь с Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π½Π΅ установлСна) 0.37%

ΠŸΠ΅Ρ€Π΅Π΄ΠΎΠ·ΠΈΡ€ΠΎΠ²ΠΊΠ°: Π² настоящСС врСмя ΠΎ случаях ΠΏΠ΅Ρ€Π΅Π΄ΠΎΠ·ΠΈΡ€ΠΎΠ²ΠΊΠΈ Π›Π°Π΅Π½Π½Π΅ΠΊΠ° Π½Π΅ ΡΠΎΠΎΠ±Ρ‰Π°Π»ΠΎΡΡŒ.

ВзаимодСйствиС с Π΄Ρ€ΡƒΠ³ΠΈΠΌΠΈ лСкарствСнными срСдствами ΠŸΡ€ΠΈ смСшивании Π›Π°Π΅Π½Π½Π΅ΠΊΠ° с Π΄Ρ€ΡƒΠ³ΠΈΠΌΠΈ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°ΠΌΠΈ, ΡΠ²Π»ΡΡŽΡ‰ΠΈΠΌΠΈΡΡ ΡΠΈΠ»ΡŒΠ½Ρ‹ΠΌΠΈ основаниями (рН Π²Ρ‹ΡˆΠ΅ 8.5), Π² Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π΅ фармацСвтичСского взаимодСйствия Π΅Π³ΠΎ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ сниТаСтся. БвСдСния ΠΎ ΠΊΠ°ΠΊΠΈΡ…-Π»ΠΈΠ±ΠΎ Π΄Ρ€ΡƒΠ³ΠΈΡ… клиничСски Π·Π½Π°Ρ‡ΠΈΠΌΡ‹Ρ… взаимодСйствиях Π›Π°Π΅Π½Π½Π΅ΠΊΠ° Π΄ΠΎ настоящСго Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ ΠΎΡ‚ΡΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‚.

ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π² ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ бСрСмСнности ΠΈ Π³Ρ€ΡƒΠ΄Π½ΠΎΠ³ΠΎ вскармливания ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π² ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ бСрСмСнности ΠΈ Π³Ρ€ΡƒΠ΄Π½ΠΎΠ³ΠΎ вскармливания ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ.

ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ ИсслСдования ΠΏΠΎ бСзопасности примСнСния Π›Π°Π΅Π½Π½Π΅ΠΊΠ° Ρƒ Π½Π΅Π΄ΠΎΠ½ΠΎΡˆΠ΅Π½Π½Ρ‹Ρ… Π΄Π΅Ρ‚Π΅ΠΉ, Π½ΠΎΠ²ΠΎΡ€ΠΎΠΆΠ΄Π΅Π½Π½Ρ‹Ρ… Π³Ρ€ΡƒΠ΄Π½Ρ‹Ρ… ΠΈ Π½Π΅ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½Π½ΠΎΠ»Π΅Ρ‚Π½ΠΈΡ… Π΄Π΅Ρ‚Π΅ΠΉ Π½Π΅ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΡŒ. ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ Π½Π΅ рСкомСндуСтся.

ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Ρƒ ΠΏΠΎΠΆΠΈΠ»Ρ‹Ρ… Богласно ΠΈΠΌΠ΅ΡŽΡ‰ΠΈΠΌΡΡ Π² настоящСС врСмя Π΄Π°Π½Π½Ρ‹ΠΌ ΠΏΠΎΠΆΠΈΠ»ΠΎΠΉ возраст Π½Π΅ являСтся ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΠ΅ΠΌ для назначСния Π›Π°Π΅Π½Π½Π΅ΠΊΠ°. Π’Π΅ΠΌ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅, ΠΏΠΎΡΠΊΠΎΠ»ΡŒΠΊΡƒ физиологичСскиС Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ Ρƒ ΠΏΠΎΠΆΠΈΠ»Ρ‹Ρ… людСй ΡƒΡ…ΡƒΠ΄ΡˆΠ°ΡŽΡ‚ΡΡ, ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π΄ΠΎΠ»ΠΆΠ½ΠΎ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΡ‚ΡŒΡΡ ΠΏΠΎΠ΄ Ρ‚Ρ‰Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»Π΅ΠΌ.

БвСдСния ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠΌ влиянии Π½Π° ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡ‚ΡŒ ΡƒΠΏΡ€Π°Π²Π»ΡΡ‚ΡŒ транспортными срСдствами, ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ ВлияниС Π½Π° ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡ‚ΡŒ ΡƒΠΏΡ€Π°Π²Π»ΡΡ‚ΡŒ транспортными срСдствами, ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ Π½Π΅ установлСно.

Π€ΠΎΡ€ΠΌΠ° выпуска Раствор для ΠΈΠ½ΡŠΠ΅ΠΊΡ†ΠΈΠΉ. По 2 ΠΌΠ» Π² Π°ΠΌΠΏΡƒΠ»Π°Ρ… Ρ‚Π΅ΠΌΠ½ΠΎΠ³ΠΎ стСкла гидролитичСского класса 2. КаТдая Π°ΠΌΠΏΡƒΠ»Π° ΠΈΠΌΠ΅Π΅Ρ‚ пятно Π±Π΅Π»ΠΎΠ³ΠΎ Ρ†Π²Π΅Ρ‚Π°, ΠΎΠ±ΠΎΠ·Π½Π°Ρ‡Π°ΡŽΡ‰Π΅Π΅ мСсто Π½Π°Π΄Π»ΠΎΠΌΠ° Π°ΠΌΠΏΡƒΠ»Ρ‹. По 10 ΠΈΠ»ΠΈ 50 Π°ΠΌΠΏΡƒΠ» Π² ΠΊΠ°Ρ€Ρ‚ΠΎΠ½Π½ΡƒΡŽ ΠΏΠ°Ρ‡ΠΊΡƒ с ΠΏΠ΅Ρ€Π΅Π³ΠΎΡ€ΠΎΠ΄ΠΊΠ°ΠΌΠΈ ΠΈΠ· ΠΊΠ°Ρ€Ρ‚ΠΎΠ½Π° с инструкциСй ΠΏΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ.

Π‘Ρ€ΠΎΠΊ годности 3 Π³ΠΎΠ΄Π°. НС ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡ‚ΡŒ ΠΏΠΎ истСчСнии срока годности, ΡƒΠΊΠ°Π·Π°Π½Π½ΠΎΠ³ΠΎ Π½Π° ΡƒΠΏΠ°ΠΊΠΎΠ²ΠΊΠ΅.

Условия хранСния ΠŸΡ€ΠΈ Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ ΠΎΡ‚ +18 Π΄ΠΎ +25Β° Π‘ Π² Π·Π°Ρ‰ΠΈΡ‰Π΅Π½Π½ΠΎΠΌ ΠΎΡ‚ свСта мСстС.
Π₯Ρ€Π°Π½ΠΈΡ‚ΡŒ Π² мСстах, нСдоступных для Π΄Π΅Ρ‚Π΅ΠΉ.

Условия отпуска ΠΈΠ· Π°ΠΏΡ‚Π΅ΠΊ По Ρ€Π΅Ρ†Π΅ΠΏΡ‚Ρƒ.

ΠŸΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡ‚Π΅Π»ΡŒ Π”ΠΆΠ°ΠΏΠ°Π½ Π‘ΠΈΠΎ ΠŸΡ€ΠΎΠ΄Π°ΠΊΡ‚Ρ Ко., Π›Ρ‚Π΄, 1-44-4, Вомигая Шибуя-ΠΊΡƒ, Π’ΠΎΠΊΠΈΠΎ, 151-0063, Япония.

Π’Π»Π°Π΄Π΅Π»Π΅Ρ† рСгистрационного удостовСрСния/организация, ΠΏΡ€ΠΈΠ½ΠΈΠΌΠ°ΡŽΡ‰Π°Ρ ΠΏΡ€Π΅Ρ‚Π΅Π½Π·ΠΈΠΈ/ Π­ΠΊΡΠΊΠ»ΡŽΠ·ΠΈΠ²Π½Ρ‹ΠΉ Π΄ΠΈΡΡ‚Ρ€ΠΈΠ±ΡŒΡŽΡ‚ΠΎΡ€ Π² России ООО ΠœΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΠ°Ρ ΠšΠΎΡ€ΠΏΠΎΡ€Π°Ρ†ΠΈΡ «РАНА», Россия, 123242, Π³. Москва, ΡƒΠ». ЗоологичСская, Π΄.22, Ρ‚Π΅Π».: +7(499) 766-27-27

90000 Buy Laennec 2 ml X 50 vials for anti-aging and skin tightening with placenta hydrolysate online from Japan 90001 90002 Basic information about Laennec 90003 90004 90005 Official manufacturer 90006: JBP Co Ltd, Japan 90007 90004 90005 Active ingredient: 90006 human placenta hydrolysate. 90007 90004 90005 Selling start 90006: July, 1979, in Japan after clinical trials (conducted throughout the Japan in 124 cases).90007 90004 90005 Official Code 90006 in Japan: 3259601A1024 90007 90004 Laennec is officially registered in USA, South Korea, China, Russia and NIS countries. 90007 90004 90023 90005 Clinically significant adverse reactions and Contraindications 90006 90026: allergic reactions are possible. 90007 90004 90005 FREE WORLDWIDE SHIPPING! WE SHIP TO YOUR COUNTRY! 90006 90007 90004 90005 BEST OFFER 789 USD FOR BANK PAYMENT ONLY — CONTACT US NOW! 90006 90007 90002 Related Articles about Laennec 90003 90004 Where can I get detailed information about clinical studies of laennec? Is Laennec a really effective medicine? What differs Laennec from similar Japanese placenta injections? If you’d like to know answers for these questions, our articles below may help you.90007 90002 Clinical studies of Laennec 90003 90004 Clinical trials were conducted throughout Japan. As a result, positive effects on blood counts such as GOT and GPT were recognized. Furthermore, Laennec was used in a number of liver and lung diseases. Similarly, it showed high regeneration and recovery effects. Studies were conducted at 95% intervals, for a more accurate effect. In addition, doctors conducted placebo tests to achieve even more accurate results. Side effects identified during the tests include allergies in 3.7% of patients. In less than one percent, itching and numbness were observed. But a clear connection between the injection and these symptoms has not been scientifically established. It is highly not recommended to use the medicine during pregnancy and breastfeeding. 90007 90004 Laennec appears in a variety of publications and scientific studies of medical subjects in Japan. For instance, the medical effect of Laennec in the treatment of the liver was investigated by the doctor Ueda Hideo.His research Acta hepatologica Japonica Vol.15 (上 η”°θ‹±ι›„ 肝 臓, vol.15 162 тисяча Π΄Π΅Π²’ятсот сімдСсят Ρ‡ΠΎΡ‚ΠΈΡ€ΠΈ (click here to follow) shows the positive effects of applying Laennec during clinical trials. Besides that, Dr. Sakamoto Koji (坂 本 ζ΅© 二) performed researches on anti -age therapy and treatment of diseases of internal organs using cell regeneration in the University of Tokyo Medical Journal (東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ). Dr. Sakamoto paid special and deep attention to detailed clinical research on side effects before launching Laennec in Japan — in the issue of 東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ, vol.33,271 (1975) as well as 東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ, vol.31,829 (1973) and in 東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ, vol.32,351 (1974).90007 90002 Dosage and administration for Laennec 90003 90004 In chronic recurrent herpes and atopic dermatitis, Laennec is injected via IV. 10 ml (560 mg of placental hydrolyzate) of the medicine (5 vials) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5 -2 h. Injections are carried out 3 times a week with an interval of 2 days. Over all, the course of treatment includes 10 injections. 90007 90004 90007 90004 In chronic liver diseases (steatohepatitis, alcoholic, metabolic, and mixed etiology), the drug is administered intramuscularly at 2 ml / day (112 mg of placental hydrolyzate).Depending on the severity of the disease, the frequency of injections can be increased up to 2-3 times (6 ml) / day. Also the medicine can be injected via IV. 10 ml (560 mg of placentae hydrolyzate) of the drug (5 ampoules) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5-2 hours. Injections are carried out daily. In that case, the course of treatment is 2-3 weeks. 90007 90004 90007 90056 BEWARE OF FALSE LAENNEC FROM KOREA AND CHINA! 90057 90004 It is very important to identify original Laennec from Chinese and Korean fake copies.Original Laennec is shipped only from Japan (from hospital). And it is never sold on domestic market, because that’s a violation of Japan Law. 90007 90004 90005 Expiration date is 1 year. Laennec manufactured in Japan differs from placenta hydrolysate manufactured in other countries. It contains tried-and-true components, it has better effec. But its shelf life is 1 year only. 90006 90007 90004 PLEASE PAY ATTENTION! 90007 90004 Expiry date is less than 1 year (about 7-9 months).One box of 50 vials is for 5-6 months course. Apply one vial every 2 days for 2 months, then repeat in 1 — 1,5 months. — 90007 90004 Product is shipped directly from Japan only. 90005 WE SHIP IN 5-7 BUSINESS DAYS. 90006 90007 90002 Laennec from Japan: Dummy or Effective medicine? 90003 90004 Certainly, clients often write us different questions about Laennec. How to get original Japanese Laennec? How to distinguish a fake and original product? And, especially recently, many people asked us whether Laennec will be effective in case of this or that disease.Some people believe it might be effective in treating cancer, oncology, stroke, kidney failure, diabetes and so on. We feel very much concerned about it because those misbeliefs might be dangerous. Where do you, dear customers, take these data (about the potential effectiveness of the Laennec in case of oncology, etc.)? We will do our best to clarify the situation once and for all. 90007 90002 What Laennec is effective for? 90003 90004 Please, remember, the Japanese Laennec is effective for the following deseases and conditions.First, liver diseases, including hepatitis. But severe cases requirs additional treatment and other medicines. Second, for skin diseases, including psoriasis, except for severe cases). Third, for the purpose of rejuvenating and antiaging therapy. The last purpose is not certified by medical supervisory authorities in number of countries. However, it has been fully proved and confirmed in Japan and the USA. The efficacy of placental preparations has been also proven in Korea, where some of JBP products are produced.90007 90002 How to identify genuine Laennec from Japan? 90003 90004 Japanese-made Laennec can be purchased only in Japan. You can not purchase it neither in China, nor in the Philippines or in Thailand! Unfortunately, fakes exist even in Japan. For instance, they are sold from companies without a license or through net auctions like Ebay. On this product page, there is a complete guide on how to distinguish the original Japanese Laennec. Customers sent us photos of goods purchased in other countries.Ampoules have different lengths, shape, heterogeneous colour etc. Prints on the packaging are dirty, leaving stains and marks. But even this is not the main point though a sufficient one. There is a simple and reliable way to distinguish a true Laennec from Japan. 90007 90056 How to identify genuine Laennec from Japan? 90057 90004 Pay attention to the packaging and the ampoules. On the packaging there is a unique three-dimensional volumetric code, which is hard enough to make and almost impossible to copy.Furthermore, on each ampoule of the Laennec there are two long numeric codes. These two codes are special labeling as required by the Japanese Medicines Act dated year 2008. The upper code is the sales lot code. And the lower code is the code of the batch of pharmaceutical raw materials used for production. In other words, one code is responsible for the sale, the second for the manufacture. 90007 90056 How to apply Laennec in right way? 90057 90004 Applying the medicine should be carried out strictly under the supervision of a specialist or doctor.Base dosages can be found on this page. The product can be used intramuscularly, intravenously and for mesotherapy. Pay attention, if there are allergic reactions or any uncomfortable sensations, the application of the Laennec should be stopped immediately. HUMAN PLACENTA. ANTI-AGING, WHITENING, MOISTURIZING 100% human Placenta Laennec. Original, directly from Japan. From Maker and official distributor. 2 ml * 50 pcs. 90007 90056 CLICK HERE AND ASK ANY QUESTION! GET ANSWER IN 24 HOURS 90057 90056 CLICK TO CHECK OUR GUARANTEES & CUSTOMER REVIEWS 90057 90004 90005 WORLDWIDE SHIPPING.FIXED RATE AS LOW AS $ 19 PER PARCEL 90006 90007 90002 How to identify original product? 90003 90004 90103 1. Original JBP package for domestic market. 90104 90007 90004 90107 90007 90004 2. Made in Japan marking on the side of original package. ( «Manufactured and Distributed by JBP Japan»). 90007 90004 90112 90007 90004 3. Expiry date and bar code. At the bottom there is a serial number of product. Specific 3D bar code with series and number (on the picture old code is shown, we always ship goods with 8-9 months ‘expiry date that is enought for full course.Box has pharma serial number and sales lot serial nuber (japanese control system). We covered series for privacy reasons. 90007 90004 90117 90007 90004 4. Ampoules of correct shape with serial number and bar code on every vial. 90007 90004 90122 90007 90004 90005 To protect privacy of our distributor we have hidden bar codes and serial number! 90006 90007 90004 5. For all laennec with expiration date of 2019.07 and further there is additional sticker added to package for protection reasons, as showm below.90007 90004 90131 90007 90002 Laennec is effective for: 90003 90004 90005 Common ailments 90006 90007 90139 90140 General fatigue 90141 90140 Stiffness of shoulders 90141 90140 Anemia 90141 90140 Raynaud disease 90141 90148 90004 90005 Male and female sexual sphere 90006 90007 90139 90140 Prostatic hypertrophy 90141 90140 Menopause and Andropause (male menopause) 90141 90140 Dysmenorrhea 90141 90140 Ovarian Dysfunction 90141 90140 Frigidity 90141 90148 90004 90005 Alimentary system 90006 90007 90139 90140 Chronic constipation 90141 90140 Gastroptosis 90141 90140 Gastric ulcer 90141 90140 Dyspepsia 90141 90140 Hepatitis 90141 90140 Liver cirrhosis 90141 90148 90004 90005 Skin 90006 90007 90139 90140 Urticaria (hives) 90141 90140 Eczema 90141 90140 Melasma 90141 90140 Keloid scar 90141 90140 Lupus 90141 90148 90002 100% HUMAN PLACENTA EXTRACT 90003 90004 100% Human Placenta Extract (HPE) is proven to be beneficial to human body.Japanese government acknowledged it as an alternative medicine for anti-aging program. Also, the American National Agency for Food and Drug did agree with that. Naturally, HPE is more compatible and harmless for humans rather than Animal Placenta Extract. Certified in Japan, USA and Korea, this is currently one of the most effective and reliable injectable medicines. 90007 90056 90005 Official Japanese Certificate 90006 90057 90004 90208 90007 90004 Delivery time — 10-15 days after the order.Order is processed at beauty clinic, Niigata prefecture. 90007 90004 90005 PRICE 789 USD FOR BANK PAYMENTS ONLY — CONTACT US NOW! 90006 90007 90004 90005 ORDER 3 BOXES BY BANK, GET 450 USD (739 USD PER BOX) DICSOUNT NOW! 90006 90007 90004 90005 You can order 10 vials here (click) 90006 90007 90004 E-mail us your name and address, we shall issue an invoice. You will purchase Original Laennec from Japan for 789 usd! When purchased online, the price is 889 usd.90007 90004 90005 FREE WORLDWIDE DELIVERY! WE SHIP TO YOUR COUNTRY! 90006 90007 .90000 Japan Bio Products Co., Ltd. 90001 90002 Laennec is the ethical drug manufactured with JBP’s unique technologies. 90003 90004 Laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver.Our product safety is ensured by the most rigid safety measures among existing scientific standards. 90005 90004 90007 Warning: 90008 90007 As LAENNEC Injection is an ethical drug, JBP has never sold it on Internet. 90008 90005 90012 90013 90014 90015 90016 90015 Ingredients 90016 90015 Content 90016 90015 Remarks 90016 90023 90014 90015 Active ingredient 90016 90015 Water-soluble substance of a product of enzymatic human placenta 90016 90015 112 mg 90016 90015 Ingredient extracted from human placenta 90016 90023 90014 90035 Inactive ingredients 90016 90015 Pepsin 90016 90015 Trace 90016 90015 Gastric mucosal extract 90016 90023 90014 90015 Lactose 90016 90015 0.6 mg 90016 90015 — 90016 90023 90014 90015 pH adjuster 90016 90015 q.s. 90016 90015 — 90016 90023 90060 90061 90004 90007 Description 90064 90008 This product is a light yellow-brown or yellow-brown clear liquid with a distinctive odor. The pH level ranges from 5.5 to 6.5 and the osmotic pressure ratio (to physiological saline) is approximately one. 90005 90004 90007 Indications 90064 90008 Improvement of hepatic function in chronic hepatic disease.90005 90004 90007 Dosage and administration 90064 90008 The normal adult dose is a 2 ml subcutaneous or intramuscular injection once daily. According to symptoms, the dose can be increased to 2 or 3 times daily. 90005 90004 90007 Packaging 90064 90008 2 ml 50 ampoules 90005 90002 Cautions for use ** 90007 90008 90003 90004 90007 1. Careful Administration 90064 90008 LAENNEC should be administrated with care in patients predisposed to allergies. 90005 90004 90007 2. Important Basic Cautions 90064 90008 This product is manufactured from the extract of human placenta delivered full-term in Japan.In order to screen each donor, a complete medical history, interviewing such as a history of travel and serologic testing for viruses, bacteria and infection are performed, after nucleic-acid testing (NAT) to meet with requirements for HBV-DNA, HCV- RNA and HIV-1-RNA is carried out. In addition, it has been confirmed that high-pressure steam sterilization for 20 minutes at 121 Β° C during the manufacturing process is effective in inactivating various viruses such as HIV etc. Furthermore, although in the product test, the nucleic-acid test meets with requirements for HBV-DNA, HCV-RNA, HIV-1-RNA, HTLV-DNA, and parvovirus B19-DNA, patients should be made aware of the following points during administration: To date, the transmission of infection, such as variant Creutzfeldt-Jakob disease (vCJD), by administration of this product in Japan or other countries has not been reported.However, although safety measures are taken to prevent infection during the manufacturing process, it is theoretically impossible to fully eliminate the risks of infection transmission originating in a human placenta used as raw material. While safety measures during the manufacturing process to prevent infection, as well as confirmation of the necessity of treatment for the disease before administration are carried out, doctors should explain to patients and try to have them understand that when human placenta is used as the raw material of a product, the risk of infection can not be fully ruled out.90005 90004 90007 3. Drug Interactions 90064 90008 When this product is directly mixed with a strong base preparation of pH 8.5 or more, attenuation of pharmacological activity has been reported. 90064 No coadministration with this product resulting in the enhancement or attenuation of the pharmacological effect of this product or concomitant drugs, appearance of adverse reactions, or aggravation of disease has been reported. 90005 90004 Adverse reactions or patients who were suspected to have suffered adverse reactions to this product were reported in a total of 10 (3.7%) of the 273 patients selected for safety evaluation in the clinical study performed during implementation of reevaluation of the drug efficacy. The most frequently observed adverse reactions were injection site pain in 7 patients (2.6%), hypersensitivity (such as rash, fever, and itching) in 1 patient (0.4%), injection site indurations in 1 patient (0.4%), and gynaecomastia in 1 patient (0.4%). The causal relationship between gynaecomastia and this product is unknown. 90064 No abnormal changes in laboratory values ​​were observed.90104 1) 90064 90106 β€’ Clinically significant adverse reactions 90064 ** Shock (incidence unknown): 90064 Since this product is a protein / amino acid preparation derived from human tissue, this product may cause a shock. If any signs of abnormality are observed, the drug should be discontinued immediately, appropriate measures should be taken and the condition should be monitored fully. 90064 β€’ Other adverse reactions (in descending order of occurrence) 90005 90111 90013 90014 90015 Injection site pain 90016 90015 2.56% 90016 90023 90014 90015 Sensitivity (rash, fever, itching etc.) 90016 90015 0.37% 90016 90023 90014 90015 Injection site indurations 90016 90015 0.37% 90016 90023 90014 90015 Gynaecomastia 90016 90015 0.37% 90016 90023 90060 90061 90004 90007 4. Use in the Elderly 90064 90008 From clinical data and present use, no particular caution is needed in the administration of this product to the elderly.However, since elderly patients often have reduced physiological function, it should be administrated with care. 90005 90004 90007 5. Use during Pregnancy. Delivery or Lactation 90064 90008 In reproductive development toxicity experiments on animals, including teratogenicity, this product can be considered not to have such toxicity. 90104 2) 90106 90005 90004 90007 6. Pediatric use 90064 90008 The safety of this product in premature infants, newborns, infants, toddlers or children has not been established due to insufficient clinical data.90005 90004 90007 7. Overdosage 90064 90008 Overdosage of this product and the resulting efficacy or safety have not been established (Due to insufficient clinical data). 90005 90004 90007 8. Precautions for Use 90064 90008 Injection site: 90064 In order to avoid any effect on tissue or nerves, the product should be injected subcutaneously or intramuscularly taking the following precautions: 90064 a) For the injection site, to avoid nerve pathways, it should be administrated with care.90064 b) In the case of repeated injections, avoid injecting into the same site by alternating on the left and right side etc. 90064 c) If intense pain or regurgitation of blood is observed, the needle should be removed immediately, and injected into a different site. 90064 Opening the ampoule: 90064 When opening the ampoule, it is preferable to wipe the part to be cut with an ethanol sponge before opening it. 90005 90004 90005 90002 Pharmacokinetics 90003 90004 The bioactive ingredients of LAENNEC are extracted from human placenta, and the primary pharmacological effects of this product can not necessarily be attributed to a single substance or ingredient.Therefore, evaluation of the pharmacokinetics (absorption, distribution, metabolism, and excretion) of this product has not been established. 90005 90004 90005 90002 Clinical studies 90003 90004 90007 1. Double blind comparison to chronic hepatitis and hepatic cirrhosis 90104 1) 90064 90106 90008 In a double-blind crossover study of 124 patients in Japan on the effects of this product on chronic hepatitis and hepatic cirrhosis, administration of this product improved serum transaminase (GOT, GPT) levels significantly (see figures below).90005 90004 Efficacy to GOT 90064 90005 90004 Efficacy to GPT 90064 90005 90004 Summary of drug-efficacy 90064 [(A) Items having a tendence to decrease or increase significantly by Laennec] 90005 90004 Data on pharmacological reevaluation 90064 Summary of drug-efficacy 90064 [(B) Items having a tendence to decrease or increase significantly by Placebo] 90005 90004 90007 2. Action on HCV-RNA levels 90104 3) 90064 90106 90008 Twenty subjects of two-agent combination therapy only with Stronger Neo-Minophagen C and Acelart were performed in the past and negativation neither of C100-3 antibody nor HCV-RNA was admitted in them.In three-agent combination therapy with Laennec added, two negative cases of serum HCV-RNA levels were admitted. 90005 90004 90005 90002 Pharmacology 90003 90004 90007 1. Stimulatory effects of hepatic reproduction 90104 4), 5) 90064 90106 90008 After 70% of livers in healthy rats was resected, time comparisons of liver weight to the control groups resulted in significant stimulation of hepatic reproduction in the Laennec groups. 90005 90004 90007 2. Stimulatory effects of cellular DNA synthesis 90104 4) 90064 90106 90008 Compared to control groups, in vivo experimental system using primary culture rat hepatocytes, the DNA-synthesis accelerator activity was observed in 2 ΞΌL / ml-administrated groups.That accelerator activity was equivalent to 10 pM of rHGF. The liver tissue in vivo experimental system using rats with acute hepatitis by ANIT was stained and the result of evaluation of the rate of hepatocyte nucleus in DNA synthesis period showed significant accelerator of DNA synthesis compared to the control groups. 90005 90004 90007 3. Inhibitory effects of experimental liver injury 90104 4), 6) 90064 90106 90008 Compared to control groups, in vivo experimental system using rats with acute hepatitis by ANIT, the liver cytosolic enzymes in serum (GPT, ALP, LAP and g -GTP) and the bilirubin levels significantly degreased in the Laennec groups.90064 In addition, compared to control groups, in vivo experimental system using rats with acute hepatitis and chronic hepatitis by CCI4, the liver cytosolic enzymes in serum (GPT, GOT) significantly degreased and histopathologically improved liver disorder in the Laennec groups. 90005 90004 90007 4. Anti-fatty liver action 90104 7) 90064 90106 90008 A 5-day subcutaneous injection of 1.2 ml / kg of this product in rats suffering from acute hepatic disorder with CCI4 resulted in a significant decrease in hepatic weight to body weight as compared with the control groups.Furthermore, total hepatic lipids and total hepatic cholesterol decreased significantly in the 3.6 ml / kg dose groups, and hepatohistological findings to support such results were seen and the body weight was realized. 90064 After pretreatment of acute hepatic disorder with CCI4, there were no significant differences with regards to biochemical findings between the control groups and when 5-day repeated, subcutaneous administration of 1.2 ml / kg of this product was performed. However, in the 3.6-ml / kg dose groups, maintenance of lobular structure was better than the control groups with regards to hepatohistological findings.90005 90004 90007 5. Absorption accelerated activity on interstitial connective tissue 90104 8) 90064 90106 90008 This product exhibited inhibitory action of fibroplasias in rat liver due to 12-week repeated administration of CCI4, and it was confirmed histologically that once multiplied, interstitial connective tissues were absorbed. 90005 90004 90005 90002 Physicochemistry 90003 90004 This product is human-placental extract, and contains various biological active substances. However, the active ingredients of this agent can not be specified as a single substance or several sorts of substances.90005 90004 90005 90002 Precautions for handling * 90003 90004 This product corresponds to a specialized biological product. Therefore, when this product is administrated, the product name, manufacturing No., date of administration (or prescription), name and address of patients should be reported and stored for at least 20 years in accordance with the order issued by the Japanese Ministry of Health, Labour and Welfare. This product should be used with attention to the point that the indication of this product is «improvement of hepatic function in chronic liver disease».90005 90004 90005 90004 90007 References 90064 90008 1) Ueda H. et al .: Kanzo (Liver), vol.15, 162, 1974 90064 2) Taniguchi H. et al .: data on file in Japan Bio Products Co. Ltd., 1985-1991 90064 3) Takami T .: Kiso to Rinsho, vol.30, 3549, 1996. 90064 4) Liu K. et al .: Yakuri to Rinsho, vol.5, 2187, 1995 90064 5) Sakamoto K . et al .: Journal of Tokyo Medical University, vol.33, 271, 1975 90064 6) Nakayama S. et al .: Folia Pharmacologica Japonica, vol.94, 289, 1989 90064 7) Sakamoto K. et al.: Journal of Tokyo Medical University, vol.31, 829, 1973 90005 .90000 Buy Laennec essence 2 ml * 50 vials for Anti-aging online at sale price 90001 90002 90003 FREE WORLDWIDE SHIPPING! WE SHIP TO YOUR COUNTRY! 90004 90005 90002 90003 BEST PRICE 789 USD FOR BANK PAYMENT ONLY — CONTACT US NOW! PAY BY BANK 90004 90005 90002 90003 ORDER 3 BOXES, GET 450 USD (739 USD PER BOX) DICSOUNT NOW! 90004 90005 90002 90003 You can also check 10 vials here (click) 90004 90005 90018 Basic information on Laennec injections.90019 90002 90003 Official manufacturer 90004: JBP Co Ltd, Japan 90005 90002 90003 Active ingredient: 90004 human placenta hydrolysate. 90005 90002 90003 Start sales 90004: in Japan after clinical trials (conducted throughout the Japan in 124 cases) of Laennec in 1979, July. 90005 90002 90003 Official Code 90004 in Japan: 3259601A1024 90005 90002 Laennec is registered in USA, South Korea, China, Russia and NIS countries officially. 90005 90002 Clinically significant adverse reactions and 90003 Contraindications 90004: allergic reactions are possible 90005 90018 Clinical studies of Laennec: regarding medical effects.90019 90002 As a result of clinical trials conducted throughout Japan, positive effects on blood counts such as GOT and GPT were recognized — laennec was used in a number of liver and lung diseases, showing high regeneration and recovery effects. Studies were conducted at 95% intervals, for a more accurate effect, placebo tests was applied to achieve more accurate results. Side effects identified during the tests include allergies in 3.7% of patients. In less than one percent, itching and numbness were observed, but a clear connection between the injection and these symptoms has not been scientifically established.It is highly not recommended to use the drug during lactation and pregnancy. 90005 90002 Laennec appears in a variety of publications and scientific studies of medical subjects in Japan. The medical effect of Laenneca in the treatment of the liver was investigated by the doctor Ueda Hideo in his research Acta hepatologica Japonica Vol.15 (上 η”°θ‹±ι›„ 肝 臓, vol.15 162 1974 (click here to follow) the positive effects of applying Laennec during clinical trials are shown. Dr. Sakamoto Koji (坂 本 ζ΅© 二) in his research on anti-age therapy and treatment of diseases of internal organs using cell regeneration in the University of Tokyo Medical Journal (東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ) pays special and deep attention to detailed clinical research on side effects before launching Laennec drug in Japan — in the issue of 東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ, vol.33,271 (1975) as well as 東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ, vol.31,829 (1973) and in東京 εŒ»η§‘ε€§ε­¦ ι›‘ θͺŒ, vol.32,351 (1974).90005 90018 Dosage and administration of Laennec 90019 90002 Dosage: In chronic recurrent herpes and atopic dermatitis, the drug is injected via IV: 10 ml (560 mg of placental hydrolyzate) of the medicine (5 vials) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5 -2 h. Injections are carried out 3 times a week with an interval of 2 days. The course of treatment 10 injections. 90005 90002 90005 90002 In chronic liver diseases (steatohepatitis / alcoholic, metabolic, and mixed etiology /), the drug is administered intramuscularly at 2 ml / day (112 mg of placental hydrolyzate).Depending on the severity of the disease, the frequency of injections can be increased up to 2-3 times (6 ml) / day. The drug can be injected via IV: 10 ml (560 mg of placentae hydrolyzate) of the drug (5 ampoules) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5-2 hours. Injections are carried out daily. The course of treatment is 2-3 weeks. 90005 90018 How to identify genuine Japanese Laennec? 90019 90002 BEWARE OF KOREAN AND CHINESE FAKE PRODUCTS! It is very important to identify original product from Chinese and Korean fake copies.Orignal product is shipped only from Japan (from hospital), and never sold on domestic market, as it is a violation of Japan Law. 90005 90002 PLEASE PAY ATTENTION! 90005 90062 90063 Expiration date is less then 1 year (about 9-10 monhs). One box of 50 vials is for 5-6 month course. Apply one vial every 2 days for 2 months, then repeat in 1 — 1,5 months. 90064 90063 Product is shipped directly from Japan. 90064 90063 ORIGINAL JAPANESE PACKAGE.MADE IN JAPAN — KURUME PLANT. 90064 90063 90003 Expiration date is 1 year. Laennec manufactured in Japan differs from Korean laennec, it contains natural components, has better effect but it’s shelf life is 1 year. 90004 90064 90063 WE SHIP IN about 5-7 business days after the order. 90064 90063 We ship 50 vials and 10 vials in original package. 90064 90077 90078 Laennec from Japan: Dummy or Effective medicine? 90079 90002 More and more often, clients write us different questions about Laennec.How to buy a original Japanese Laennec, how to distinguish a fake and original product and, especially recently, whether Laennec will be effective in case of his or that disease. Customers keep asking if it be effective in treating cancer, oncology, stroke, kidney failure, diabetes and so on. A list of questions about the efficacy of Laennec from Japan in this or that disease can be continued on and on. Where do you, dear customers, take these data (about the potential effectiveness of the Laennec in case of oncology, etc.) ?. We will do our best to clarify the situation once and for all. 90005 90078 What Laennec is effective for? 90079 90002 Please, remember, the Japanese Laennec is effective for liver diseases, including hepatitis (but severe case requires additional treatment and other drugs), for skin diseases (including psoriasis, except for severe cases), as well as for the purpose of rejuvenating and antiaging therapy. The last item is not certified by medical supervisory authorities in number of countries, but it has been fully proved and confirmed in Japan and the USA.The efficacy of placental preparations has been also proven in Korea, where some of JBP products are produced. In Japan laennec is also applied for skin tightening and general cellular anti-aging therapy. 90005 90078 How to buy genuine Laennec from Japan? 90079 90002 Japanese-made Laennec can be purchased only in Japan. Neither in China, nor in the Philippines or in Thailand, you can not buy it! And even in Japan there are fakes, when they are sold from companies without a license or on net auctions like Ebay.On this product page, there is a complete guide on how to distinguish the original drug and buy real, Japanese, Japanese-manufactured goods. Customers sent us photos of goods purchased in other countries — ampoules have different lengths, shape, heterogeneous colour etc. Prints on the packaging are dirty, leaving stains and marks. But even this is not the main thing though a sufficient one. There is a simple and reliable way to distinguish a true Laennec from Japan. 90005 90078 How to identify genuine Laennec from Japan? 90079 90002 Pay attention to the packaging and the ampoules.On the packaging there is a unique three-dimensional volumetric code, which is hard enough to make and almost impossible to copy. Furthermore, on each ampoule of the Laennec there are two long numeric codes. These two codes are special labeling as required by the Japanese Medicines Act dated year 2008. The upper code is the sales lot code, the lower code is the code of the batch of pharmaceutical raw materials used for production. That is, everything is simple enough — one code is responsible for the sale, the second for the manufacture.90005 90078 How to apply Laennec in right way? 90079 90002 Applying the drug should be carried out strictly under the supervision of a specialist or doctor. Base dosages can be found on this page. The drug can be used intramuscularly, intravenously and for mesotherapy. Pay attention, if there are allergic reactions or strange / uncomfortable sensations, the application of the Laennec should be stopped immediately. 90005 90018 Articles about Laennec 90019 90002 You may be interested to check the following articles related to laennec from our blog section: 90005 90002 90005 90002 90005 90002 HOW TO IDENTIFY ORIGINAL PRODUCT? 90005 90002 90109 1.Original JBP package for domestic market. 90110 90005 90002 90005 90002 90115 90005 90002 2. Made in Japan marking on the side of original package. ( «Manufactured and Distributed by JBP Japan»). 90005 90002 90120 90005 90002 3. Expiry date and bar code. At the bottom there is a serial number of product. Specific 3D bar code with series and number (on the picture old code is shown, we always ship goods with 8-9 months ‘expiry date that is enought for full course.Box has pharma serial number and sales lot serial nuber (japanese control system). We covered series for privacy reasons. 90005 90002 90125 90005 90002 4. Ampoules of correct shape with serial number and bar code on every vial. 90005 90002 90130 90005 90002 90003 To protect privacy of our distributor we have hidden bar codes and serial number! 90004 90005 90002 5. For all laennec with expiration date of 2019.07 and further there is additional sticker added to package for protection reasons, as showm below.90005 90002 90139 90005 90002 WHITENING, ANTI-AGING MOISTURIZING 90005 90002 90005 90002 90003 100% human Placenta Laennec (Original, Directly from Japan — from Maker and official distributor). 90004 90005 90002 90005 90002 90005 90002 90003 ALSO CHECK LAENNEC — 50 pcs — FOLLOW THE LINK 90004 90005 90002 90003 90159 90004 90005 90002 90003 LAENNEC — 50 pcs 90004 90005 90002 90005 90002 Effective for: 90005 90002 90005 90002 1.general fatigue 2.Stiffness of shoulders 3.Astma 4.Urticaria (hives) 5.Migraine 6. Prostatic hypertrophy 7.Menopause 8. Andropause (male enopause) 9. Dysmenorrhea 10.Ovarian Dysfunction 11.Frigidity 12.Oligogalactia 13. Gestational toxicosis 14.Chronic constipation 15. Gastroptosis 16.Gastric ulcer 17. Stomack cancer 18.Dyspepsia 19.Hypertension 20.Hypotension 21.Neuralgia 22.Neurosis 23. Hepatitis 24. Liver cirrhosis 25. Retinal pigmenttary dystrophy 26.Cataract 27.Iritis 29. Hearing loss 30.Tinnitus 31.Anemia 32.raynaud disease 33.lupus 34.Nocturnal Enurosis (bed-wetting) 35.Eczema 36.Melasma 37.Skin Allergy 38.Skin cancer 39.Keloid scar. 90005 90002 90005 90002 100% HUMAN PLACENTA EXTRACT 90005 90002 90005 90002 The fact that 100% Human Placenta Extract was proven to be beneficial to human body. Japanese government had no doubts in acknowledging it as an alternative medicine for anti-aging program. Even the American Food and Drug Agency did conform with the Japanese Government on this issue.Knowing the high medical standard of the Japanese government, 100% HPE has meticulously pass its standards. Undoubtful and sure, most of the modern beauty enthusiasts has been using 100% for ANTI-AGING, WHITENING and MOSTURIZING agent. Which is, BETTER than BOTOX. It also harmless and more compatible for humans to use rather than from four legged animals. And take note, 100% HPE is not only for anti-aging programs! It has also many benefits to offer for human. The following mentioned below are just some of the ailment that can be treated by 100% HPE.90005 90002 90005 90002 Certified in Japan, Korea, USA, this is currently the most reliable and effective injectable drug. 90005 90002 90005 90002 90003 Official Japanese Certificate. 90004 90005 90002 90193 90005 .90000 LAENNEC | μ£Όμ‹νšŒμ‚¬ 일본 생물 제제 90001 90002 Laennec is the ethical drug manufactured with JBP’s unique technologies. 90003 90004 Laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver.Our product safety is ensured by the most rigid safety measures among existing scientific standards. 90005 90004 90007 Warning: 90008 90007 As the LAENNEC Injection is an ethical drug, JBP has never sold it on Internet. 90008 90005 90012 90013 90014 90015 90016 90015 Ingredients 90016 90015 Content 90016 90015 Remarks 90016 90023 90014 90015 Active ingredient 90016 90015 Water-soluble substance of a product of enzymatic human placenta 90016 90015 112 mg 90016 90015 Ingredient extracted from human placenta 90016 90023 90014 90035 Inactive ingredients 90016 90015 Pepsin 90016 90015 Trace 90016 90015 Gastric mucosal extract (pig) 90016 90023 90014 90015 Lactose 90016 90015 0.6 mg 90016 90015 — 90016 90023 90014 90015 pH adjuster 90016 90015 q.s. 90016 90015 — 90016 90023 90060 90061 90004 90007 Description 90064 90008 This product is a light yellow-brown or yellow-brown clear liquid with a distinctive odor. The pH level ranges from 5.5 to 6.5 and the osmotic pressure ratio (to physiological saline) is approximately one. 90005 90004 90007 Indications 90064 90008 Improvement of hepatic function in chronic hepatic disease.90005 90004 90007 Dosage and administration 90064 90008 The normal adult dose is a 2 ml subcutaneous or intramuscular injection once daily. According to symptoms, the dose can be increased to 2 or 3 times daily. 90005 90004 90007 Packaging 90064 90008 2 ml 50 ampoules 90005 90002 Cautions for use ** 90007 90008 90003 90004 90007 1. Careful Administration 90064 90008 LAENNEC should be administrated with care in patients predisposed to allergies. 90005 90004 90007 2. Important Basic Cautions 90064 90008 This product is manufactured from the extract of human placenta delivered full-term in Japan.In order to screen each donor, a complete medical history, interviewing such as a history of travel and serologic testing for viruses, bacteria and infection are performed, after nucleic-acid testing (NAT) to meet with requirements for HBV-DNA, HCV- RNA and HIV-1-RNA is carried out. In addition, it has been confirmed that high-pressure steam sterilization for 20 minutes at 121 Β° C during the manufacturing process is effective in inactivating various viruses such as HIV etc. Furthermore, although in the product test, the nucleic-acid test meets with requirements for HBV-DNA, HCV-RNA, HIV-1-RNA, HTLV-DNA, and parvovirus B19-DNA, patients should be made aware of the following points during administration: To date, the transmission of infection, such as variant Creutzfeldt-Jakob disease (vCJD), by administration of this product in Japan or other countries has not been reported.However, although safety measures are taken to prevent infection during the manufacturing process, it is theoretically impossible to fully eliminate the risks of infection transmission originating in a human placenta used as raw material. While safety measures during the manufacturing process to prevent infection, as well as confirmation of the necessity of treatment for the disease before administration are carried out, doctors should explain to patients and try to have them understand that when human placenta is used as the raw material of a product, the risk of infection can not be fully ruled out.90005 90004 90007 3. Drug Interactions 90064 90008 When this product is directly mixed with a strong base preparation of pH 8.5 or more, attenuation of pharmacological activity has been reported. 90064 No coadministration with this product resulting in the enhancement or attenuation of the pharmacological effect of this product or concomitant drugs, appearance of adverse reactions, or aggravation of disease has been reported. 90005 90004 Adverse reactions or patients who were suspected to have suffered adverse reactions to this product were reported in a total of 10 (3.7%) of the 273 patients selected for safety evaluation in the clinical study performed during implementation of reevaluation of the drug efficacy. The most frequently observed adverse reactions were injection site pain in 7 patients (2.6%), hypersensitivity (such as rash, fever, and itching) in 1 patient (0.4%), injection site indurations in 1 patient (0.4%), and gynaecomastia in 1 patient (0.4%). The causal relationship between gynaecomastia and this product is unknown. 90064 No abnormal changes in laboratory values ​​were observed.90104 1) 90064 90106 β€’ Clinically significant adverse reactions 90064 ** Shock (incidence unknown): 90064 Since this product is a protein / amino acid preparation derived from human tissue, this product may cause a shock. If any signs of abnormality are observed, the drug should be discontinued immediately, appropriate measures should be taken and the condition should be monitored fully. 90064 β€’ Other adverse reactions (in descending order of occurrence) 90005 90111 90013 90014 90015 Injection site pain 90016 90015 2.56% 90016 90023 90014 90015 Sensitivity (rash, fever, itching etc.) 90016 90015 0.37% 90016 90023 90014 90015 Injection site indurations 90016 90015 0.37% 90016 90023 90014 90015 Gynaecomastia 90016 90015 0.37% 90016 90023 90060 90061 90004 90007 4. Use in the Elderly 90064 90008 From clinical data and present use, no particular caution is needed in the administration of this product to the elderly.However, since elderly patients often have reduced physiological function, it should be administrated with care. 90005 90004 90007 5. Use during Pregnancy. Delivery or Lactation 90064 90008 In reproductive development toxicity experiments on animals, including teratogenicity, this product can be considered not to have such toxicity. 90104 2) 90106 90005 90004 90007 6. Pediatric use 90064 90008 The safety of this product in premature infants, newborns, infants, toddlers or children has not been established due to insufficient clinical data.90005 90004 90007 7. Overdosage 90064 90008 Overdosage of this product and the resulting efficacy or safety have not been established (Due to insufficient clinical data). 90005 90004 90007 8. Precautions for Use 90064 90008 Injection site: 90064 In order to avoid any effect on tissue or nerves, the product should be injected subcutaneously or intramuscularly taking the following precautions: 90064 a) For the injection site, to avoid nerve pathways, it should be administrated with care.90064 b) In the case of repeated injections, avoid injecting into the same site by alternating on the left and right side etc. 90064 c) If intense pain or regurgitation of blood is observed, the needle should be removed immediately, and injected into a different site. 90064 Opening the ampoule: 90064 When opening the ampoule, it is preferable to wipe the part to be cut with an ethanol sponge before opening it. 90005 90004 90005 90002 Pharmacokinetics 90003 90004 The bioactive ingredients of LAENNEC are extracted from human placenta, and the primary pharmacological effects of this product can not necessarily be attributed to a single substance or ingredient.Therefore, evaluation of the pharmacokinetics (absorption, distribution, metabolism, and excretion) of this product has not been established. 90005 90004 90005 90002 Clinical studies 90003 90004 90007 1. Double blind comparison to chronic hepatitis and hepatic cirrhosis 90104 1) 90064 90106 90008 In a double-blind crossover study of 124 patients in Japan on the effects of this product on chronic hepatitis and hepatic cirrhosis, administration of this product improved serum transaminase (GOT, GPT) levels significantly (see figures below).90005 90004 Efficacy to GOT 90064 90005 90004 Efficacy to GPT 90064 90005 90004 Summary of drug-efficacy 90064 [(A) Items having a tendence to decrease or increase significantly by Laennec] 90005 90004 Data on pharmacological reevaluation 90064 Summary of drug-efficacy 90064 [(B) Items having a tendence to decrease or increase significantly by Placebo] 90005 90004 90007 2. Action on HCV-RNA levels 90104 3) 90064 90106 90008 Twenty subjects of two-agent combination therapy only with Stronger Neo-Minophagen C and Acelart were performed in the past and negativation neither of C100-3 antibody nor HCV-RNA was admitted in them.In three-agent combination therapy with Laennec added, two negative cases of serum HCV-RNA levels were admitted. 90005 90004 90005 90002 Pharmacology 90003 90004 90007 1. Stimulatory effects of hepatic reproduction 90104 4), 5) 90064 90106 90008 After 70% of livers in healthy rats was resected, time comparisons of liver weight to the control groups resulted in significant stimulation of hepatic reproduction in the Laennec groups. 90005 90004 90007 2. Stimulatory effects of cellular DNA synthesis 90104 4) 90064 90106 90008 Compared to control groups, in vivo experimental system using primary culture rat hepatocytes, the DNA-synthesis accelerator activity was observed in 2 ΞΌL / ml-administrated groups.That accelerator activity was equivalent to 10 pM of rHGF. The liver tissue in vivo experimental system using rats with acute hepatitis by ANIT was stained and the result of evaluation of the rate of hepatocyte nucleus in DNA synthesis period showed significant accelerator of DNA synthesis compared to the control groups. 90005 90004 90007 3. Inhibitory effects of experimental liver injury 90104 4), 6) 90064 90106 90008 Compared to control groups, in vivo experimental system using rats with acute hepatitis by ANIT, the liver cytosolic enzymes in serum (GPT, ALP, LAP and g -GTP) and the bilirubin levels significantly degreased in the Laennec groups.90064 In addition, compared to control groups, in vivo experimental system using rats with acute hepatitis and chronic hepatitis by CCI4, the liver cytosolic enzymes in serum (GPT, GOT) significantly degreased and histopathologically improved liver disorder in the Laennec groups. 90005 90004 90007 4. Anti-fatty liver action 90104 7) 90064 90106 90008 A 5-day subcutaneous injection of 1.2 ml / kg of this product in rats suffering from acute hepatic disorder with CCI4 resulted in a significant decrease in hepatic weight to body weight as compared with the control groups.Furthermore, total hepatic lipids and total hepatic cholesterol decreased significantly in the 3.6 ml / kg dose groups, and hepatohistological findings to support such results were seen and the body weight was realized. 90064 After pretreatment of acute hepatic disorder with CCI4, there were no significant differences with regards to biochemical findings between the control groups and when 5-day repeated, subcutaneous administration of 1.2 ml / kg of this product was performed. However, in the 3.6-ml / kg dose groups, maintenance of lobular structure was better than the control groups with regards to hepatohistological findings.90005 90004 90007 5. Absorption accelerated activity on interstitial connective tissue 90104 8) 90064 90106 90008 This product exhibited inhibitory action of fibroplasias in rat liver due to 12-week repeated administration of CCI4, and it was confirmed histologically that once multiplied, interstitial connective tissues were absorbed. 90005 90004 90005 90002 Physicochemistry 90003 90004 This product is human-placental extract, and contains various biological active substances. However, the active ingredients of this agent can not be specified as a single substance or several sorts of substances.90005 90004 90005 90002 Precautions for handling * 90003 90004 This product corresponds to a specialized biological product. Therefore, when this product is administrated, the product name, manufacturing No., date of administration (or prescription), name and address of patients should be reported and stored for at least 20 years in accordance with the order issued by the Japanese Ministry of Health, Labour and Welfare. This product should be used with attention to the point that the indication of this product is «improvement of hepatic function in chronic liver disease».90005 90004 90005 90004 90007 References 90064 90008 1) Ueda H. et al .: Kanzo (Liver), vol.15, 162, 1974 90064 2) Taniguchi H. et al .: data on file in Japan Bio Products Co. Ltd., 1985-1991 90064 3) Takami T .: Kiso to Rinsho, vol.30, 3549, 1996. 90064 4) Liu K. et al .: Yakuri to Rinsho, vol.5, 2187, 1995 90064 5) Sakamoto K . et al .: Journal of Tokyo Medical University, vol.33, 271, 1975 90064 6) Nakayama S. et al .: Folia Pharmacologica Japonica, vol.94, 289, 1989 90064 7) Sakamoto K. et al.: Journal of Tokyo Medical University, vol.31, 829, 1973 90005 .
Leave a Reply

Π”ΠΎΠ±Π°Π²ΠΈΡ‚ΡŒ ΠΊΠΎΠΌΠΌΠ΅Π½Ρ‚Π°Ρ€ΠΈΠΉ

Π’Π°Ρˆ адрСс email Π½Π΅ Π±ΡƒΠ΄Π΅Ρ‚ ΠΎΠΏΡƒΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½. ΠžΠ±ΡΠ·Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ поля ΠΏΠΎΠΌΠ΅Ρ‡Π΅Π½Ρ‹ *